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ABSTRACT 
 
MOLECULAR CANDIDATES FOR BLOCKING THE TRANSMISSION OF VECTOR-
BORNE DISEASES 
 
Ashish Naresh Vora 
Old Dominion University, 2018 
Director: Dr. Hameeda Sultana 
Vector-borne diseases (VBDs) require urgent attention as they have a high 
mortality rate, with 700,000 people dying in a year as of 2017. So far, extremely few 
reliable vaccination strategies and solutions have emerged. Transmission blocking 
vaccines are one among many solutions available to manage the control of VBDs. 
These require identification of both vector and pathogen molecules that play important 
roles in the transmission, dissemination and establishment of VBDs. Our strategy is to 
characterize these candidates that play important roles in vector-host-pathogen 
interactions. This manuscript presents two such studies identifying the participation of 
two arthropod molecules in vector-host-pathogen interactions.  The first study uses 
quantitative and standard PCR to detect dengue serotypes DENV2/3 RNA and 
immunoblotting to detect viral proteins within mosquito extracellular vesicles (EVs). The 
EVs carry infectious viral RNA and are able to establish infection in naïve, recipient cells 
of various lineages. Mosquito EVs mediate DENV2 transmission through a newly 
identified mosquito exosome marker, designated as Tsp29Fb, an orthologue of human 
CD63. Silencing Tsp29Fb reduced DENV2 load, it’s interaction with DENV2 E-protein 
and transmission of DENV2 through EVs.  
Our second study identifies another arthropod molecule in ticks. The tick HSP70-
like molecule is involved in disrupting the host coagulation pathway through the 
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induction of fibrinogenolysis. Immunoblotting analysis revealed reduced D-Dimer, a 
fibrin degradation product, in ticks fed on immunocompromised hosts. In addition, ticks 
fed on immunocompromised hosts exhibit a lower expression of the arthropod HSP70-
like molecule that correlated with higher engorgement weights. This differential activity 
is linked to the immune states and/or background of the vertebrate host, in this case 
mice.  Inhibition of the tick HSP70-like molecule in the salivary gland lysates of fed ticks 
abrogates its fibrinogenolytic activity. These studies together identify two strong 
candidates playing different roles for blocking the transmission of VBDs from two 
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 Vector-borne diseases (VBDs) caused over 1.1 million deaths in 2002 and 
700,000 deaths in 2017 that comprise of 17% of all infectious diseases (WHO 2004, 
2017). Out of the 700,000 deaths in 2017, 400,000 were due to malaria, which remains 
the leading VBD today (WHO 2017). Other major VBDs include Leishmaniasis, 
Trypanosomiasis, Yellow fever, Dengue, Chagas disease and Japanese encephalitis 
fever, in descending order of their mortality rates (WHO 2004, 2017.) There are over 19 
million species of arthropods, some of which carry or are known to carry and transmit 
deadly diseases to humans (Ødegaard, 2000). The leading arthropod vectors of disease 
are mosquitoes and ticks (Conway et al., 2014; Neelakanta and Sultana, 2015) and can 
be used as models for studying VBDs.  
 So far, the VBD management strategies have involved direct treatment of 
disease, blocking acquisition and transmission of pathogens and finally vector 
population control (Conway et al., 2014). Out of these the most successful strategy we 
have today is vector control which involves the use of physical barriers, pesticides, 
repellents, and attractants (Conway et al., 2014; Foster and Hancock, 1994; Kato et al., 
2008). There is also a sterile insect technique involving the release of transgenic insects 
with dominant lethality to reduce vector population (Harris et al., 2012). Direct treatment 
of viral infections has not been very successful due to a lack of available antiviral 
treatment options and the therapy involves just palliative care (Katzelnick et al., 2017a, 
2017b; Whitehorn and Simmons, 2011). Blocking acquisition involves either the 
identification of arthropod molecules important for viral pathogenesis or use of biological 
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agents like Wolbachia that play a role in suppressing viral replication (Cheng et al., 
2010; Glaser and Meola, 2010; Mousson et al., 2012; Perera-Lecoin et al., 2013). 
However, a major problem with these strategies is that it cannot prevent a primary 
infection from the pathogen.  
This leaves transmission blocking strategies as the new promising avenue for 
investigation. The blocking of transmission would also require the identification of 
molecular players that facilitate the transmission of pathogen or those that suppress the 
host’s immune system (Conway et al., 2014; Neelakanta and Sultana, 2015; Zhou et al., 
2018). The candidates considered as targets for blocking transmission have to match 
certain criteria to be of high quality. These criteria outline that the target should be 
indispensable for vector-pathogen interaction and silencing of the target should lead to 
a direct reduction in pathogen load, dissemination and pathogenesis. The primary 
amino acid sequence of the candidate should be highly conserved among the 
population of the vector species. It should be able to generate a high antibody titer and 
be compatible with multiple adjuvants. Finally, the target molecule should not generate 
an exaggerated immune response leading to immunological disorders in the host 
(Neelakanta and Sultana, 2015).  
The best place to look for these molecular players lies at the host-vector-
pathogen interface i.e. at the bite site of an infected vector. Many studies have been 
performed to determine the absolute importance of vector-attachment and host-seeking 
behavior of the vectors in order for them to secure a blood meal (Brossard and Wikel, 
2004; Francischetti et al., 2009; Hovius et al., 2008; Ribeiro and Francischetti, 2003; 
Ribeiro et al., 2007; Wikel, 2013), without which there would not be any physical 
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channel to transmit the pathogen. Several other studies have been performed to show 
that vector saliva enhanced the chance of establishing and increased the severity of 
infection, only some of which are cited here (Ader et al., 2004; Jones et al., 1989; 
Kročová et al., 2003; Labuda et al., 1993; Le Coupanec et al., 2013; Schneider et al., 
2004; Styer et al., 2011; Surasombatpattana et al., 2014). These molecules are of 
myriad classes and have multiple functions which include behaviors like anti- 
hemostasis, anti-inflammation, immunosuppression, anti-coagulation, vasodilation etc. 
(Calvo et al., 2010; Neelakanta and Sultana, 2015; Ribeiro et al., 2007). Hence, this 
vector-pathogen-host interface provides an ideal area for the search of molecular 
candidates for blocking transmission of VBDs. 
 With this in mind, this manuscript highlights two studies that show evidence 
fulfilling the first requirement of a molecular candidate to block transmission of VBDs. 
The first study published in 2018, focuses on how a newly identified tetraspanin domain 
containing glycoprotein mediates the transmission of dengue virus through mosquito 
extracellular vesicles. The second study published in 2017 focuses on the role of a tick 
HSP70 and the differential feeding response elicited by ticks upon feeding on hosts with 
different immune backgrounds.  
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MOSQUITO EXTRACELLULAR VESICLES MEDIATE DENGUE VIRUS 





Dengue is a major VBD, which according to the 2017 WHO report puts 3.9 billion 
people at risk of infection (Brady et al., 2012). There are 96 million reported cases of 
dengue with observable symptoms worldwide every year with actual number of 
infections estimated to be over 300 million (Bhatt et al., 2013). A subset of these 
infections, around 500,000 are severe infections with symptoms of hemorrhage and 
multiple organ failure leading to 19,000 deaths every year (Yacoub et al., 2013). 
Attempts at developing and distributing vaccines for dengue has been challenging, 
compounded by four serotypes (DENV1-4) and the antibody dependent enhancement 
of the disease (Halstead and O’Rourke, 1977; Katzelnick et al., 2017a). The only 
approved vaccine, Dengvaxia for dengue is not broadly protective and has been pulled 
off the market (Hadinegoro et al., 2015). So far there are no drugs available for 
treatment and management of the disease is limited to vector control and supportive 
care (Conway et al., 2014).  
The life cycle of dengue virus is like most other flaviviruses. Figure 1 shows the 
standard model for dengue virus entry into the cells (Cruz-Oliviera et al., 2015). There is 
a direct interaction of mature viruses with host cell receptors which then leads to 
receptor mediated endocytosis (Cruz-Oliveira et al., 2015; Perera-Lecoin et al., 2013; 
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Vega-Almeida et al., 2013). During the late endosomal stage, the low-pH triggers a 
conformational change in the viral envelope (E)-protein, which fuses with the endosomal 
membrane. Thus, releasing the genomic content of the virus directly into the cytosol 
(Cruz-Oliveira et al., 2015; Rodenhuis-Zybert et al., 2010). Once inside, the positive 
sense RNA genome gets translated to produce the RNA-dependent RNA polymerase 
encoded by the viral RNA. This polymerase is then further able to replicate the viral 
genome leading to translation of more viral proteins. Eventually the viral proteins are 
assembled and the immature virus is passed through the trans-Golgi network (Cruz-
Oliveira et al., 2015; Rodenhuis-Zybert et al., 2010). At this stage there is cleavage of 
furin on the virus that leads to its maturation and subsequent release through budding 
off from the membrane (Cruz-Oliveira et al., 2015; Rodenhuis-Zybert et al., 2010). The 
dengue genome is ~11kb long and consists of three structural proteins (M, C and E) 
and seven non-structural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5). 
Out of these, multiple studies have reported the involvement of the dengue NS1 protein 
in the contribution to viral toxicosis through suppression of the interferon response and 
increasing viral toxicity (Guzman et al., 2010; Halstead, 2015). 
 Exosomes or small extracellular vesicles (EVs) have been shown to carry a 
range of molecules including protein, RNA and even DNA (Colombo et al., 2014; 
Gonzales et al., 2009; Théry et al., 2002; Villarroya-Beltri et al., 2014). Figure 2 shows 
multi-vesicular endosomes (MVEs) containing intra-luminal vesicles that are released in 
the extra cellular space when the endosomes fuse with the plasma membrane  
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Figure 1. Life Cycle of Dengue Virus. Beginning on the top-left the image shows the receptor mediated 
endocytosis of a mature dengue virus. The virus once taken inside the cell is present in the endosome 
which when progresses to the late endosomal stage becomes acidic in pH. The acidic pH triggers the 
fusion of the viral envelop with the endosomal membrane making the virus release its contents into the 
cytoplasm. The RNA genetic material of dengue virus begins replicating and simultaneously gets 
translated to produce the viral proteins. The viral RNA and proteins pass through the trans-Golgi network 
to produce a mature dengue virus particle which is released into the extra-cellular space through 
exocytosis. This image is reproduced from a paper on the dengue virus life cycle (Rodenhuis-Zybert et 
al., 2010). 
 
(Colombo et al., 2014; Théry et al., 2002). The small 30-150 nm sized EVs are 
known as exosomes. Bigger sized EVs with sizes ranging from 150-1000 nm diameters 
are known to directly bud off from the plasma membrane and are classified as 
microvesicles (Colombo et al., 2014; Théry et al., 2002). Some studies have shown the 
presence of virus components in mammalian exosomes (Arakelyan et al., 2017; 
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Ramakrishnaiah et al., 2013). Previously published work from Dr. Sultana laboratory 
was the first to characterize the role of arthropod EVs in pathogen transmission (Zhou et 
al., 2018).  This formed the basis of our hypothesis that dengue, which is a positive 
single-stranded RNA virus could also be transmitted through EVs.  
Figure 2. Biogenesis of Extracellular Vesicles. Exosomes (30-150 nm) are formed through 
invaginations in the early endosome, giving rise to small vesicles called intraluminal vesicles. As these 
endosome progress to the late endosomal stage known as multivesicular bodies, they contain 
intraluminal vesicles loaded with various molecules. The multivesicular body through exocytotic 
mechanisms fuses with the plasma membrane to release these vesicles in the extracellular space which 
are then known as exosomes. Larger EVs (> 150 nm) can pinch of directly from the plasma membrane 
and are classified as microvesicles. This image is adapted from a paper published on the recent 
advancements on the use of exosomes as drug delivery vehicles (Bunggulawa et al., 2018). 
 
 This study shows for the first time, the presence of the full-length DENV2 RNA 
genome and viral proteins in mosquito cell derived EVs and that these EVs are able to 
establish an infection in naïve recipient cells from different lineages. These findings 
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provide important data for the current and future avenues in understanding biology of 
arthropod EVs in pathogen transmission which is a rapidly expanding field (Alenquer 
and Amorim, 2015; Barile and Vassalli, 2017; Hackenberg and Kotsyfakis, 2018; 
Madison and Okeoma, 2015; Schorey et al., 2015). To determine whether there are any 
molecules that can be used to block transmission of disease through EVs, this study 
investigated two molecules that are enriched in EVs, HSP70 and the mosquito 
orthologue of human CD63 (LAMP3), Tsp29Fb. The results of which indicate that 
Tsp29Fb plays an important role in transmission of DENV2 though EVs. The human 
CD63 has also been implicated in the entry and exit of the human immunodeficiency 
virus (HIV) (Li et al., 2014). Collectively, this study is not only critical in understanding 
the molecular basis of the modes of flaviviral transmission from the arthropod vector, 
but may also potentially lead to the development of better strategies to interfere with the 
life cycle of this and perhaps other medically important vectors. 
 
  





Mosquito Cell-Derived EVs Contain DENV2 RNA and Proteins  
Figure 3 shows increasing dengue load with time in Aedes albopictus mosquito 
cell line (C6/36). Figure 3A shows a significant increase in the dengue burden in C6/36 
cells, Figure 3B in C6/36 EVs and Figure 3C in Aedes aegypti mosquitoes (in vivo). 
Since the viral load (both in cell line and in vivo) was high at 72 hpi (hours post-
infection), we selected this time point for the isolation of EVs from mosquito cells. Figure 
4A and 4B show the two different ultracentrifugation techniques used for the isolation of 
EVs from in vitro cultures. Cryo-electron microscopy (cryo- EM)  data generated in 
collaboration with colleagues Drs. Woodsone and Sherman at UTMB were performed 
on C6/36 EVs showed the presence of 30– 250 nm diameter EVs (Figure 5A), which 
bear resemblance to EVs isolated from mammalian cells as described in literature 
(Tauro et al., 2012; Théry et al., 2002). Figure 5B shows the detection of A. albopictus 
HSP70 in each of the infected or uninfected EV fractions 2-6, with the highest level in 
fraction 4 (Figure 5B). HSP70 was not detected in fraction 1 from EVs isolated from 
uninfected or DENV2-infected groups (Figure 5B) indicating the absence of EVs (since 
HSP70 is an EV marker). Figure 5B also shows increased presence of HSP70 in 
infected EVs in comparison to uninfected fractions. DENV2 E-protein was higher in 
infected EV fraction 5 in comparison to the other fractions (Figure 5B). Immunoblotting 
also revealed both DENV2- glycosylated (Figure 5B, upper band) and endogenous 
(lower band) E-protein in fraction 5 and 6. E-protein was not detected in uninfected 
controls. The Ponceau S-stained images showed total protein profile in each fraction. 
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Further quantitative real-time PCR (qRT-PCR) showed DENV2 total capsid transcripts 
in EVs derived from infected C6/36 cells (Figure 5C). The same result was derived for 
DENV3 capsid RNA in EVs derived from DENV3 infected A. albopictus cells. This 
suggests that EVs may act as mediators of all serotypes of DENVs (Figure 5D). DENV2 
E and nonstructural 1 (NS1) proteins were also detected in C6/36 cell lysates and EVs 
(Figure 5E). E-protein level was higher in EVs in comparison with cell lysates at 72 hpi, 
whereas no difference was observed with NS1 protein levels in either EVs or total cell 
lysates (Figure 5E). Similar pattern of E-protein levels are seen in DENV3-infected 
C6/36 cell-derived EVs and total cell lysates (Figure 5F). Coomassie-stained gel images 
show the total protein profiles in both DENV2 and DENV3 groups (Figure 5E and 5F). 
Quantification of A. albopictus EVs showed the highest prevalence of EV sizes were 
between 50 and 100 nm in both uninfected and DENV2-infected groups (Figure 6A and 
6B). Figure 6A and 6B also show that DENV2-infected cell-derived EVs had a higher 
percentage of EVs in the size range 0-50 nm and fewer 100–150 nm sized EVs in 
comparison to the uninfected EVs. This suggests that DENV2 may stimulate production 
of smaller EVs. Figure 6C shows the counts of total number of EVs from uninfected or 
DENV2-infected A. albopictus cells obtained from cryo-EM images collected from at 
least three independent isolations. The counts did have a significant difference. For 
biochemical quantification of EVs, we determined their total protein amounts using the 
Bradford protein assay (BCA). Extracellular vesicles isolated from various number of 
cells show a linear increase for EV proteins (Figure 6D and 6E). There was a negligible 
difference in the EV protein amounts from infected or uninfected samples. These data 
correlate with data in Figure 6A, 6B and 6C. DG-EV isolation performed determined 
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whether EVs contain viral particles and the size of EVs that contain the viral particles. 
An independent DG-EV isolation by filtering the culture supernatants with 0.22-μM filters 
that yielded 12 fractions showed similar results (Figure 6F). To determine if A. 
albopictus cell-derived EVs contain the full-length DENV2 genome, Mr. Wenshuo Zhou 
(graduate student with Dr. Neelakanta) with support from Dr. Neelakanta performed a 
PCR analysis (with oligonucleotides producing overlapping amplicons covering entire 
DENV2 sequence) was performed (Figure 7A). The result shows the presence of the 
full-length DENV2 genome in C6/36 cell-derived EVs. Fragments 1–10 amplified 
products of 1,102 bp, 1,110 bp, 1,124 bp, 1,114 bp, 1,118 bp, 1,141 bp, 1,104 bp, 1,135 
bp, 1,110 bp, and 1,048 bp. Fragment 11 (3′ end of the genome) amplified multiple 
products, including the expected size of 717 bp.  This may be due to the looped nature 
of the 3′ end of the genome.  
 
DENV2 RNA and Proteins are Securely Contained Inside the EVs  
To eliminate the possibility of DENV2 viruses being present outside of the EVs, 
we performed cryo-EM analysis on 6 C6/36 cell-derived DG-EV fractions (Figure 7B). 
The infected EV fractions did not show any virions either inside or outside of these EVs. 
These data suggest that viral RNA and proteins are perhaps sufficient for the infection 
of naïve recipient cells. To determine if the viral RNA is bound to the EV exterior and 
are thus delivered to the recipient cells, we treated our infected cell derived EVs and 
viral stocks with RNase A (Figure 8A, 8B). DENV2 loads were determined from cells 
exposed to RNase treated and untreated EVs. We obtained similar results with no 
difference in the viral load in the C6/36 cells upon incubation with EVs or laboratory viral 
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stocks prepared from DENV2-infected RNaseA-treated or untreated groups. To confirm 
that the viral proteins too are contained inside the mosquito cell-derived EVs, and are 
not on the exterior as contaminants, we designed and performed an E-protein 4G2-
antibody bead binding assay. There were no differences in viral loads between infected 
EV fractions treated with either 4G2 antibody (that binds to viral E-protein) or with the 
isotype control or the untreated controls (Figure 8C). We also tested the DENV2 
laboratory stock as a control that showed reduced DENV2 loads in the recipient C6/36 
cells in comparison with the isotype antibody-treated or untreated controls (Figure 8D). 
In addition, we performed native-PAGE followed by immunoblotting with 4G2 antibody 
on infected A. albopictus EVs treated with 0.1% Triton X-100 for 30 min at room 
temperature, or treated with multiple freeze-thaw cycles or untreated samples. A higher 
level of E-protein (in native state at ∼200–250 kDa) was detected in Triton X-100– 
treated EV fractions in comparison with the levels in untreated or freeze-thawed 
fraction. Ponceau S-stained images showed the total protein profile and served as 
control. Immunofluorescence analysis with 4G2 antibody showed that EVs treated/lysed 
with 0.1% of Triton X-100 had a higher fluorescent signal for DENV2 E-protein in 
comparison with untreated EV fractions (Figure 8F). Enzyme linked immunosorbent 
assay (ELISA) with 4G2 (an anti-E-protein antibody) further supported the native- PAGE 
and immunofluorescence analyses, where higher loads of DENV2 E-protein were 
detected when EVs were permeabilized with 0.1% of Triton X-100 in comparison with 
untreated controls (Figure 8G). Taken together all of these data suggest that DENV2 
RNA and proteins contained inside the A. albopictus EVs are not present as 
contaminants on the outside.  
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DENV2 Infectious RNA and Proteins are Transmitted to Mosquito, Murine, and 
Human Cells through A. albopictus EVs  
To determine if DENV2 RNA and proteins contained in A. albopictus cell-derived 
EVs are viable and infectious to arthropod/ vertebrate host cells, we used EVs and EV-
depleted supernatants (EDS; generated during EV pelleting and before PBS wash) 
(Figure 4B). Immunofluorescence assays performed on naïve C6/36 cells treated with 
infectious EVs showed a greater fluorescent signal for E-protein in comparison to EDS-
treated cells (Figure 9A). Higher concentrations of EVs showed similar results (Figure 
9A). Infectious A. albopictus EVs and EDS were also tested in plaque assays (Figure 
9B). A. albopictus cell-derived infectious EV pellet fractions yielded plaques at dilutions 
of 1:10 that were too numerous to count, and around 25–30 plaques at a dilution of 
1:100, and fewer than 5 plaques in dilutions of 1:1000. EDS treatment of A. albopictus 
cells yielded no plaques. Further, we analyzed whether EVs derived from infected A. 
albopictus are capable of transmitting DENV2 to other cell types. The result in Figure 
9C shows a successful transmission and reinfection ability of A. albopictus EVs to naïve 
mosquito C6/36 cells, mouse Mo-DCs, HaCaT cells, and HUVEC cells. No viral loads 
were detected in any tested cell lines incubated with EDS (Figure 9C). The infection of 
DENV2 in several other cell lines was assessed using dengue stock, which showed 
detectable a load at 72 hpi (Figure 10B–10E). Infected A. albopictus cell derived EVs 
were introduced to naïve cells used in Figure 10C-10E. Overall, these results suggest 
that DENV2 viral RNA and proteins exit mosquito cells via EVs, and that these 
infectious EVs mediate transmission of DENVs to human cells. 
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Role of A. albopictus HSP70 in EV-mediated DENV2 Transmission  
The qRT-PCR data in this section was contributed by Mr. Wenshuo Zhou, for the 
published manuscript (Vora et al., 2018). Figure 5 and 6 demonstrate that the A. 
albopictus HSP70 is present in EVs derived from mosquito cells. To determine if the A. 
albopictus HSP70 plays a role in the EVs  mediate transmission dengue, we 
investigated the role of two isoforms of hsp70 (GenBank accession nos. JN132154 and 
XM_019672019). Quantitative RT-PCR revealed that both hsp70 isoforms were 
upregulated in C6/36 cells upon infection at 48 h and 72 hpi in comparison with 24 hpi 
and uninfected controls (Figure 11A, 11B). The hsp70 transcript (GenBank accession 
no. JN132154) was undetectable in EVs. The presence of hsp70 transcript GenBank 
accession no. XM_019672019 was evident in EVs, without a significant change in 
expression between uninfected and infected EVs (Figure 11C). Immunoblotting showed 
an increased expression of HSP70 in EVs isolated from infected cells at 24 hpi in 
comparison to 48 and 72 hpi and uninfected samples (Figure 11D). No change in 
expression of HSP70 was observed between uninfected or infected C6/36 cell lysates 
(Figure 11D).  Coomassie-stained gel images show the total protein profiles in EVs and 
total cell lysates. In addition, we tested the effect of inhibiting HSP70 on DENV2 
transmission through EVs. QRT-PCR showed that C6/36 cells treated with VER-155008 
(HSP70 inhibitor), followed by infection with DENV2 had significantly reduced 
expression of hsp70 (XM_019672019, in comparison to the mock- (DMSO) treated 
group (Figure 11E). No change was observed in XM_019672019 transcript expression 
in EVs derived from these inhibitor-treated and DENV2-infected C6/36 cells (Figure 
11E). Treatment with VER-155008 inhibitor did not decrease DENV2 load in either total 
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cell or EV lysates (Figure 11F). The effects of VER-155008 inhibitor-treated infectious 
EVs and EDS from the same batch were tested on naïve C6/36 cells. No difference was 
observed in DENV2 loads in the inhibitor-treated group compared to the mock (Figure 
11G). Similar results were obtained for EDS treated cells. As expected, DENV2 loads in 
EV fractions showed significant differences compared with the EDS fractions. All these 
data indicate that the up-regulation of A. albopictus HSP70 as an arthropod stress 
response during DENV2 infection, but inhibition of this critical chaperone does not lead 
to the reduction in viral burden or transmission.  
 
Identification of a Mosquito EV Marker Tsp29Fb, a Tetraspanin Domain- 
containing Glycoprotein  
The human CD63 or LAMP-3 proteins are well-established markers for EVs/ 
exosomes (Colombo et al., 2014; Gonzales et al., 2009; Théry et al., 2002; Villarroya-
Beltri et al., 2014). Hence, we decided to investigate the mosquito ortholog of human 
CD63 as a marker of and mediator for the transmission of DENV2 through EVs. Using a 
human CD63 primary amino acid sequence, (GenBank accession no. AHI151903) as a 
query in the VectorBase, we identified tetraspanin domain-containing mosquito 
orthologs in both A. aegypti (AAEL012532-RA) and A. albopictus (AALF020630- RA) 
and designated these orthologs as Tsp29Fb. ClustalW alignment of an A. aegypti 
Tsp29Fb amino acid sequence (Figure 12A) revealed 89% identity with A. albopictus 
Tsp29Fb and 51% identity with Drosophila melanogaster tetraspanin 29Fb protein 
(GenBank accession no. AAF90138). Aedes aegypti Tsp29Fb showed 28% and 27% 
identity with human and mouse CD63 (GenBank accession no. CAJ18387), 
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respectively. A phylogenetic analysis revealed that A. aegypti Tsp29Fb lies within the 
same clade as A. albopictus Tsp29Fb and D. melanogaster tetraspanin 29Fb. The 
human and mouse CD63s form a different clade (Figure 12B). Domain analysis of the 
A. aegypti Tsp29Fb sequence revealed the presence of the tetraspanin domain (amino 
acids 15–238), four transmembrane regions (amino acids 19–41, 56–78, 90–112, 211–
233), four myristoylation sites (amino acids 37–47, 76–82, 92–98, 228–234), and two 
glycosylation sites (amino acids 125–129, 168–172) (Figure 12C). The identification of 
an ortholog of the EV/ exosome marker CD63 named Tsp29Fb in the mosquito genome 
suggests the presence of a putative EV marker in mosquitoes.  
 
DENV2 Infection Up-regulates Tsp29Fb Expression in Mosquito EVs and Cells  
To explore the function of Tsp29Fb in EV mediated transmission of DENV2 in 
mosquitoes, we analyzed its expression in DENV2- infected A. aegypti mosquitoes (in 
vivo) (Figure 13A). The results show very significant up regulation of tsp29Fb 
(accession no. AAEL012532-RA) at 24, 48, and 72 hpi, in comparison to uninfected 
mosquitoes. Similar expression patterns were observed in Aag-2 cells, derived from A. 
aegypti mosquitoes. Quantitative RT-PCR analysis showed that in both Aag-2 EVs and 
in cells, tsp29Fb was up-regulated upon infection at 48 and 72 hpi compared to 
uninfected samples (Figure 13B, 13C). Quantitative RT-PCR also revealed significantly 
higher transcripts of tsp29Fb (accession no. AALF020630-RA) at 24 and 48 hpi in 
C6/36 cell-derived EVs (Figure 12D), and at 48 and 72 hpi in whole-cell lysates (Figure 
12E). Time and MOI dependent expression of Tsp29Fb was also analyzed using 
immunoblotting (Figure 13F and 13B). The results determined that for C6/36 cell-
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derived EV fractions and whole-cell lysates at different time points of 24, 48, and 72 hpi, 
had higher Tsp29Fb protein expression in infected lysates in comparison to uninfected 
samples (Figure 11F). This correlated with the qPCR data in Figure 13D and 13E. 
Tsp29Fb expression is also upregulated with increasing infectious dose of DENV2 
(Figure 13G). Total protein profiles in all four panels served as loading controls (Figure 
13F and 13G). These data show that Tsp29Fb is upregulated both in vivo and in vitro 
upon DENV2 infection.  
 
Tsp29Fb Directly Interacts with DENV2 Envelope Protein  
For further characterization of Tsp29Fb’s function in facilitating DENV2 infection 
and transmission, we tested if it directly interacts with DENV2 E-protein. 
Immunoprecipitations (IPs) performed with a human CD63 antibody and DENV2-
infected EVs and whole-cell lysates (suspended in modified RIPA protein lysis buffer; 
150 μg as input in each group) showed the presence of DENV2 E-protein by 
immunoblotting with 4G2, an anti- E-protein antibody (Figure 13H). The direct 
interaction of Tsp29Fb to DENV2 E-protein was increased in cell lysates in comparison 
to EV lysates. This could be due to a higher total amount of Tsp29Fb protein in cell 
lysates than in EVs. An E-protein signal was not detected in uninfected controls. Figure 
13I shows an IP of Tsp29Fb using PBS suspended intact arthropod EVs (freshly 
isolated) using human CD63 antibody followed by immunoblotting with 4G2 antibody. 
This too detected the precipitation of DENV2 E-protein in both mosquito cell-derived EV 
fractions and whole cell lysates (we used 500 μg as input in each group for IP with PBS 
suspended EV fractions). Coomassie blue-stained gel images showing total protein 
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profile of input lysates used for IP served as controls. We also show that Tsp29Fb 
neither interacts nor co-precipitates with actin in either EVs or total cell lysates (Figure 
14B). These data served as a negative control for the direct interaction of Tsp29Fb with 
DENV2 E-protein (Figure 13H and 13I). Actin protein immunoblots from both cells and 
EVs lysates (resuspended in RIPA buffer) that were used as input for the IP assay 
serve as a control (Figure 14C). These data suggest the presence of actin in input 
lysates that neither interact nor co-precipitate with Tsp29Fb. Immunofluorescence 
performed on A. albopictus cells showed co-localization of Tsp29Fb (Figure 14A) with 
DENV2 E-protein in infected cells. Uninfected C6/36 cells and nuclei-stained (DAPI) 
images served as controls. Altogether, these data indicate a role for mosquito EV 
marker Tsp29Fb in facilitating infection and transmission of dengue virus through direct 
interaction with the viral E-protein.  
 
Inhibition of Tsp29Fb Reduces DENV2 Infection  
We investigated the effect of inhibiting Tsp29Fb function to study its effect on 
dengue replication and transmission through EVs. We generated the dsRNA against the 
tsp29fb gene and sequenced it (Figure 15A and 15B) Transfection with tsp29fb dsRNA 
resulted in lower tsp29Fb transcripts (Figure 16A) in Aag-2 cells and EVs. DENV2 load 
in the same samples was significantly reduced (Figure 16B). Immunoblotting showed 
the same result, with reduced E-protein and Tsp29Fb protein expression in both EVs 
and total cell lysates compared to mock (Figure 16C). Total protein profiles shown by 
Coomassie-stained gel served as loading controls. Blocking Tsp29Fb using the human 
CD63 antibody in mosquito cells resulted in a reduced dengue load in EVs, cells at the 
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transcriptional and translational level (Figure 16D-16F). Total protein profiles shown by 
Coomassie-stained gels served as controls (Figure 16F). Significant differences with 
CD63 antibody treatments and silencing suggest that inhibition of Tsp29Fb reduces 
DENV2 load in cells that ultimately inhibits transmission of viral RNA and proteins via 
EVs.  
 
GW4869 Inhibitor Reduces DENV2 load, Transmission and Tsp29Fb Interaction 
with DENV2 E-protein  
Treatment of C6/36 cells with GW4869 an EV/ exosome release inhibitor 
followed by DENV2 infection showed reduction in the DENV2 capsid transcript in EVs, 
compared with the DMSO control (Figure 16G). Similar results were obtained with 
immunoblotting analysis with anti- E-protein antibody at 18 and 24 hpi, in both infected 
C6/36 cell-derived EVs and cell lysates in comparison with the DMSO controls (Figure 
16H). Longer incubation duration with the inhibitor resulted in further reduction of E-
protein expression at 24 hpi in comparison to 18 hpi. Total protein profiles shown by 
Coomassie-stained gels served as control. Infection of naïve C6/36 cells with EVs 
derived from GW4869 inhibitor treated, infected mosquito cells showed reduced DENV2 
viral RNA in the recipient cells in comparison with the DMSO control (Figure 16I). A 
transwell assay was performed with C6/36 cells on top and HUVEC cells at the bottom. 
The C6/36 cells were infected with DENV2 stock, EVs or EVs in addition to GW4869 
(Figure 16J). The dengue load was determined in the HUVEC cells 48 hpi and shown to 
be reduced in the inhibitor treated samples. The exosome inhibitor was also shown to 
reduce the direct interaction of Tsp29Fb with the dengue E-protein through an IP 
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performed with CD63 antibody and lysates from infected C6/36 cells. DMSO treated 
samples were used as control (Figure 16K). These data indicate that the reduction in 
EV release reduces dengue load and that the direct interaction of Tsp29Fb with E-
protein is not only required for DENV2 infection and pathogenesis in the arthropod host, 
but also is essential for transmission of infectious EVs to the human host. 
 
Figure 3. DENV2 Infection Kinetics in C6/36 Cells, EVs and Mosquitoes.  
(A and B) QRT-PCR analysis showing viral loads in DENV2-infected (5 MOI) C6/36 cells (n = 4) or in EVs 
(n = 6) derived from DENV2-infected C6/36 cells Uninfected C6/36 cells or cell-derived EVs were used as 
controls.  
(C) QRT-PCR analysis showing DENV2 load in A. aegypti mosquitoes (n = 4). (Note: The data in panel C 
was contributed by Mr. Wenshuo Zhou towards the publication of this data in Vora et al., 2018) DENV2 
capsid mRNA levels were normalized to mosquito actin level. The value of p determined by Student’s 
two-tailed t test is shown. 
 
B C A 
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Figure 4. Schematic Representation of the Methods Used for EV Isolation from Mosquito Cells.  
(A) Schematic representation of OptiPrep TM (DG-EVs-iso) using density gradients of iodixanol.  
(B) A regular ultracentrifugation technique used for EV isolation.  
  
A B A B 
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Figure 5. Continued.  
(A) Cryo-EM images showing EVs isolated from uninfected or DENV2-infected (MOI 5, 72 hpi) C6/36 
cells. Scale bar, 100 nm. (Note: The cryo-EM images were contributed by Drs. Woodson and Sherman at 
UTMB).  
(B) Immunoblotting from DG-EV-iso preparation showing enhanced DENV2 E-protein level and HSP70 in 
fractions 4–6. EVs derived from uninfected cells serve as control. Total protein profiles from both groups 
shown for comparison. Fraction number and calculated iodixanol density (g/mL) shown for reference.  
(C and D) QRT-PCR analysis showing DENV2 or DENV3 load in EVs isolated from C6/36 cells at 72 hpi 
(n = 5). DENV2/ DENV3 capsid mRNA levels were normalized to mosquito actin levels. The p value 
determined by Student’s two-tail t test shown.  
(E) Immunoblotting showing detection of DENV2 E-protein and NS1 in EVs and total lysates from whole 
cells prepared from uninfected (UI) or infected (I) C6/36 cells at 72 hpi (MOI 5).  
(F) DENV3-specific E-protein in EVs and total cell lysates from uninfected (UI) or infected (I) C6/36 cells 
at 72 hpi (MOI 5) is shown. Protein sizes are indicated as kilo Daltons. Images showing total protein 
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Figure 6. Estimation and Quantification of C6/36 EVs upon DENV2 Infection. 
(A and B) Heterogeneous size distribution of EVs isolated from uninfected or DENV2-infected C6/36 cells 
is shown. Y-axis represent number and X-axis indicate size range (e.g. 0-50 nm, in diameter) of EVs in 
each group. The total number of EVs considered from different cryo-EM images is indicated as ‘n’. 
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(C) EVs numbers were counted from uninfected and DENV2-infected (MOI 5, 72 hpi) groups. The Y-axis 
represents EVs number. ‘n’ indicates total number of images used in this quantification. Data shown in (A-
C) was generated by Mr. Wenshuo Zhou.  
(D) and E)  Quantification of arthropod EVs by measurement of total protein amounts (BCA method) from 
uninfected or DENV2-infected (MOI 5, 72 hpi) EVs isolated from increasing density of 104, 105,106, 107 
and 108 cells is shown from respective groups. Total EV protein concentration (measured as μg/μl) is 
plotted against increasing cell number/density.  
(F) Detection of DENV2 E-protein and EVs marker HSP70 in EVs derived as twelve fractions during 
independent DG-EV isolation. Immunoblotting analysis from iodixanol density gradient EVs preparations 
filtered through 0.22 μm showing enhanced DENV2 E-protein levels in fractions 9-12 from infected (MOI 
5; 72 hpi) C6/36 cells. HSP70 was detected in all fractions and serve as EV marker. Total protein profile 
from each fraction is shown for comparison. Fraction number and calculated iodixanol density (g/mL) is 
shown on top for reference. 
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Figure 7. Continued.  
(A) Agarose gel images showing amplification of overlapping fragments from full-length genome in 
arthropod EVs derived from DENV2-infected (5 MOI, 48 hpi) C6/36 cells. The cDNA derived from total 
RNA was used as template. PCR generated 11 fragments (fragment sizes are shown in methods) show 
the full-length DENV2 genome amplification. UI and I indicate uninfected and infected groups 
respectively. NTC indicates no template control. M indicates DNA marker.  
(B) Cryo-EM images showing EVs isolated from DENV2-infected (MOI 5; 72 hpi) C6/36 cells. EVs 
isolated by density gradient (DG-EVs-iso) fractions are shown. Fractions are labeled from 1-6. Scale bar 
indicates 100 nm in all six fractions. Panel (A) PCR was performed by Mr. Wenshuo Zhou and Panel B 
images generated by Drs. Woodson and Sherman. 
B 
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Figure 8. Continued.  
(A) QRT-PCR analysis showing DENV2 loads in naïve C6/36 cells (incubated with EVs derived from 
independent batch of DENV2 infected (MOI 5; 72 hpi) C6/36 cells treated with RNase A). Uninfected 
treated samples serve as control (n = 4).  
(B) QRT-PCR analysis showing DENV2 loads in naïve C6/36 cells infected via either infectious EVs 
derived from DENV2-infected (MOI 5, 72 hpi) C6/36 cells from an independent batch or DENV2 
laboratory viral stocks with known virus titer (MOI 5) and treated with RNase A. The untreated samples 
serve as control (n = 6).  
(C) QRT-PCR analysis showing viral load in EVs samples isolated from C6/36 DENV2-infected cells (MOI 
5; 72 hpi) that were treated with 4G2 or isotype matched control antibodies. Untreated EVs samples 
served as control (n = 6). ‘ns’ indicates not significant in (B) and (C). DENV2 capsid mRNA levels were 
normalized to mosquito actin levels in (A, B and C).  
(D) QRT-PCR analysis showing viral loads in DENV2 laboratory viral stocks (MOI 5) that were treated 
with 4G2 or isotype matched control antibodies. Untreated group was used as control (n = 6). DENV2 
levels were normalized to total RNA in (D) as actin is not detectable.  
(E) Native-PAGE followed by immunoblotting analysis showing presence of E-protein from DENV2-
infected (MOI 5; 72 hpi) C6/36 cell-derived EVs (I) treated with Triton-X-100 (0.1%), or freeze-thaw cycles 
or untreated samples held on ice. Ponceau S stained blot image showing total protein profiles serve as 
loading control. EVs isolated from uninfected cells (UI) were used as controls.  
(F) Relative fluorescence measurements from EVs (derived from DENV2-infected C6/36 cells at 72 hpi) 
treated with 0.1% Triton X-100 is shown. Untreated group was used as control (n = 6).  
F G 
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(G) ELISA showing increased detection of E-protein from EVs isolated from C6/36 DENV2-infected cells 
(MOI 5; 72 hpi) upon treatment with 0.1% Triton X-100 in comparison to untreated control (n = 4). The p 
value was determined by Student’s two-tail t test is shown. 
Figure 9. EVs Derived from Mosquito Cells Are Infectious and Transmit DENV2 to Both Arthropod 
and Mammalian Cells.  
(A) Fluorescent microscopic images showing detection of E-protein in C6/36 cells infected via EVs 
derived from independent batch of DENV2-infected (MOI 5; 72 hpi) C6/36 cells. EDS-treated cells serve 
as control (n = 5) (Scale bar, 200 μm.).  
B C 
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(B) Quantitative assessment of number of plaques on Vero cells treated with EVs (in different dilutions) or 
EDS fractions (as similar dilution) derived from DENV2-infected (MOI 5, 72 hpi) C6/36 cells are shown. 
TNTC indicates “too numerous to count” (n = 2).  
(C) QRT-PCR analysis showing viral loads at 72 hpi in naïve C6/36 or mouse dendritic or human HaCaT 
or HUVEC cells treated with EVs or EDS fractions derived from DENV2- infected (MOI 5, 72 hpi) C6/36 
cells are shown (n = 3 for each cell line). ND indicates not detectable. Depending on the cells that were 
used, DENV2 capsid mRNA levels were normalized to mosquito, mouse, or human actin levels. 
Figure 10. Re-Infection of Mosquito Cells via Infectious EVs and Infection Kinetics of DENV2 in 
Various Mammalian Cell Lines.  
(A) Fluorescent microscopic images showing detection of E-protein in C6/36 cells infected with EVs 
diluted 10-fold that corresponds to 12.6 μg of total EVs protein as estimated by the BCA, derived from 
independent batch of DENV2-infected (MOI 5; 72 hpi) C6/36 cells. The C6/36 cells treated with EVs-
depleted supernatant (EDS) fractions serve as control (n = 5). Scale bar indicates 200 μm in each image. 
(B, C, D and E) QRT-PCR analysis showing viral loads in DENV2-infected Vero cells at indicated time 
A B 
C D E 
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points (of 48, 72 and 96 hpi), mouse-derived dendritic cells at 72 hpi, human HaCaT cells at 72 hpi, and 
human HUVEC cells at 72 hpi. Cells were infected with laboratory virus stocks (MOI 5). Uninfected cells 
were used as controls (n = 3). DENV2 capsid mRNA levels were normalized to mouse or human actin 
levels, respectively. Human actin primers were used to determine the actin levels in Vero cells. 
 
Figure 11. Role of HSP70 in A. albopictus EV-Mediated DENV2 Transmission.  
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Figure 11. Continued.  
(A and B) QRT-PCR analysis showing expression of A. albopictus- HSP70 isoform-1 (Accession number 
JN132154) (n = 6) or expression of HSP70 isoform-2 (Accession number XM_019672019) (n = 6) in 
C6/36 cell lysates collected from uninfected (UI) or DENV2-infected (I) (MOI 5; 72 hpi) groups. Samples 
analyzed from 24, 48, and 72 hpi are shown for both isoforms.  
(C) XM_019672019 levels in EVs derived from DENV2-infected (MOI 5) C6/36 cells at 24, 48 and 72 hpi 
is shown. Uninfected C6/36 cell-derived EVs collected at similar time points serve as control (n = 6).  
(D) Immunoblots showing expression levels of HSP70 in EVs derived from uninfected or DENV2- infected 
(MOI 5) samples and total cell lysates is shown from different time points (24, 48 and 72 hpi) of infection. 
Total protein profiles from Coomassie stained gel images serve as controls for both cell and EVs lysates. 
HSP70 molecular mass is indicated as 70 kDa.  
(E) QRT-PCR analysis showing expression of HSP70 isoform-2 in C6/36 cells treated with VER-155008 
inhibitor for 4 h followed by DENV2 (MOI 5, 72 hpi) infection is shown. Also, EVs lysates collected from 
these C6/36 cells treated and infected (as shown above) is shown for comparison (n = 4).  
(F) DENV2 load in C6/36 cells or EVs is shown. C6/36 cells were treated with VER-155008 inhibitor at 
indicated doses followed by DENV2 infection (MOI 5, 72 hpi) and EVs were derived from the same cells 
(n = 4).  
(G) Reinfection of naïve C6/36 cells with EVs derived from VER-155008 inhibitor treated and DENV2-
infected (MOI 5, 72 hpi) or EDS is shown. C6/36 cells were treated with mock (DMSO) serve as controls 
in (E, F and G) (n = 4). HSP70 or DENV2 capsid mRNA levels were normalized to mosquito actin levels. 
The p value determined by Student’s two-tail t test is shown. The qPCR analysis for this figure was 
performed by Mr. Wenshuo Zhou. 
F G 
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Figure 12. Alignment and Phylogenetic Analysis of A. aegypti Tsp29Fb.  
(A) The deduced A. aegypti Tsp29Fb amino acid sequence alignment (with other orthologs) using 
ClustalW program in DNASTAR Lasergene is shown. Residues that match are shaded in black color. 
GenBank accession numbers for D. melanogaster tetraspanin 29Fb, M. musculus and H. sapiens CD63 
sequences are shown. VectorBase accession numbers for A. aegypti and A. albopictus Tsp29Fb are 
provided. Ruler on the top of alignment indicates number of amino acids. Total length of the amino acid 
sequence is provided at one end of each sequence.  
(B) Phylogenetic analysis was performed in DNASTAR by ClustalW slow/ accurate alignment method. 
Scale at the bottom denotes amino acid substitutions per 100 amino acid residues.  
(C) Domain analysis of A. aegypti Tsp29Fb primary amino acid sequence at PROSITE (ExPASy) is 
shown. A. aegypti Tsp29Fb contain one highly conserved tetraspanin domain, 4 transmembrane regions, 





   
 
35 
Figure 13. DENV2 Induces the Expression of Tsp29Fb, a Putative EV-Enriched Marker in Mosquito 
Cells.  
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Figure 13. Continued.  
(A, B and  QRT-PCR analysis showing expression of A. aegypti tsp29fb in uninfected (UI) or DENV2-
infected (I) whole mosquitoes at 24, 48, and 72 hpi (n = 4), or in EVs isolated from an uninfected or 
infected (MOI 5) in vitro cell line or in Aag-2 whole-cell lysates at (n = 4).  
(D and E) QRT-PCR analysis showing expression of A. albopictus tsp29fb in EVs  isolated from 
uninfected or infected (MOI 5) C6/36 cells or in whole-cell lysates at 24, 48, and 72 hpi (n = 8). DENV2 
capsid mRNA or tsp29fb levels were normalized to mosquito actin levels. The p value determined by 
Student’s two-tail t test is shown.  
(F) Immunoblotting analysis showing levels of Tsp29Fb and viral E-protein in EV derived from uninfected 
or DENV2-infected (MOI 5) C6/36 cells or in whole-cell lysates at 24, 48, and 72 hpi.  
(G) Immunoblotting analysis showing presence of Tsp29Fb and viral E-protein in EVs derived from 
uninfected or DENV2-infected (MOI 5, 72 hpi) C6/36 cells or in whole-cell lysates upon infection with 
different viral doses (MOI 1–5) is shown.  
(H and I) Immunoblotting analysis of Tsp29Fb IP proteins in RIPA or in 1 x PBS buffer with 4G2 antibody 
showing detection of viral E-protein in EVs or whole-cells lysates derived from DENV2-infected (MOI 5, 72 
hpi) C6/36 cells. Uninfected cells were used as controls in all assays. Gel images showing total protein 
H I 
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profiles in (F–I) serve as loading control for respective immunoblots. Tsp29Fb and DENV2 E-protein 
molecular mass is indicated as kilo Daltons. 
Figure 14. Tsp29Fb Co-Localizes with DENV2 E-protein and Does Not Precipitate with Actin.  
(A) Fluorescent microscopic images of uninfected (UI) or DENV2-infected (I) (MOI 5) C6/36 cells at 72 
hpi, probed with DAPI (blue), Tsp29Fb (green) and E-protein (red) is shown. Merged images show co-
localization of E-protein with Tsp29Fb (yellow) (n = 5) and counter staining with DAPI. Scale bar indicates 
200 μm.  
(B) Immunoblotting analysis of Tsp29Fb immunoprecipitated proteins in RIPA buffer with actin 
monoclonal antibody revealed no co-precipitation in either EVs or whole cells lysates derived from 
DENV2-infected (MOI 5; 72 hpi) C6/36 cells. Uninfected cells were used as controls.  
(C) Immunoblotting analysis of input lysates from DENV2-infected (MOI 5, 72 hpi) and uninfected C6/36 
cells showing level of actin being present in the same lysates used for immunoprecipitation assay. Total 
protein profile images showing Coomassie stained proteins serve as control. Expected actin molecular 
mass is indicated as kDa. 
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Figure 15. PCR Amplification of A. aegypti Tsp29Fb DNA Fragment  
(A) Agarose gel image showing amplification of A. aegypti tsp29fb DNA fragment used for synthesis of 
dsRNA. Oligonucleotides were designed based on AAEL012532 sequence.  
(B) Nucleotide sequence of A. aegypti tsp29fb dsRNA clone is shown.  
Figure 16. RNAi-Mediated Silencing or Antibody Blocking of Tsp29Fb or Treatment with GW4869 
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Figure 16. Continued.  
(A) QRT-PCR analysis showing expression of A. aegypti tsp29fb to reveal silencing efficiency or,  
(B) viral burden  in whole-cell lysates or EVs derived from DENV2- infected (MOI 2, 24 hpi) Aag-2 cells 
treated with mock or Tsp29Fb dsRNA (n = 6).  
(C) Immunoblotting analysis showing levels of A. aegypti Tsp29Fb or viral E-protein in whole-cell lysates 
or EVs derived from DENV2-infected (MOI 2, 24 hpi) Aag-2 cells treated with mock or tsp29fb dsRNA.  
(D and E) QRT-PCR (n = 3) or,  
(F) immunoblotting analysis showing viral burden in EVs or whole-cell lysates derived from DENV2-
infected (MOI 5, 72 hpi) C6/36 cells treated with Tsp29Fb antibody at different doses (of 5 and 10μg). 
Untreated, infected (MOI 2, 72 hpi) C6/36 cells were used as controls in (D–F).  
(G) QRT-PCR (n = 4) or,  
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(H) immunoblotting analysis showing viral burden in EVs or whole-cell lysates derived from DENV2-
infected (MOI 2) C6/36 cells at 72 hpi or at 18 or 24 hpi. Samples in (H) were treated with GW4869 
inhibitor at different doses (of 5–20 μM).  
(I) QRT-PCR analysis showing viral burden in naïve C6/36 cells at 48 hpi, (reinfection) upon treatment 
with EVs derived from DMSO- or GW4869-treated DENV2-infected (MOI 2, 72 hpi) C6/36 cells (n = 4).  
(J) QRT-PCR analysis showing viral load at 48 hpi in HUVEC cells in a transwell assay performed with 
C6/36 cells (in upper chamber) and naïve HUVEC cells (in lower chamber) treated with EVs derived from 
DENV2-infected (MOI 2, 72 hpi) C6/36 cells (25 μL, in upper chamber) in the presence or absence of 
GW4869. C6/36 cells infected with DENV2 laboratory stocks were used as control (n = 4). The p value 
determined by Student’s two-tailed t test is shown.  
(K) Immunoblotting analysis of Tsp29Fb IP proteins with 4G2 antibody and EVs or whole-cell lysates 
derived from DMSO- or GW4869-treated infected (MOI 2, 24 hpi) C6/36 cells. Tsp29Fb and DENV2 E-
protein molecular mass is indicated in kilo Daltons. Coomassie-stained gel images showing total protein 
profiles in (C, F, H, and K) serve as a loading control for the respective immunoblots. 
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Table 1. Oligonucleotides Used for DENV, tsp29fb, hsp70 and actin 
Primers (5'-3') Purpose 
AATATGCTGAAACGCGAGAGAAACCGCG Dengue 2, QPCR 
CTCTTCAGTATCCCTGCTGTTGG Dengue 2, QPCR 
AATATGCTGAAACGCGTGAGAAACCGTG Dengue 3, QPCR 
CTAGCCAAGACTCCTGCTGTTGG Dengue 3, QPCR 
CCATGTACGTCGCCATCCA Mosquito actin 
GCGGTGGCCATTTCCTG Mosquito actin 
AGTTGTTAGTCTACGTGGACCGACA Dengue 2, fragment 1 amplification 
GAGTGGCAGGTTGTTTGGCT Dengue 2, fragment 1 amplification 
CAGGAGGAAGCTGGGTTGACA Dengue 2, fragment 2 amplification 
GTCCCGGCTCTACTCCTATGATGA Dengue 2, fragment 2 amplification 
GTCAACCCAATCGTAACAGAAAAAGA Dengue 2, fragment 3 amplification 
CTCCAGAGGGTGTGTGACTTTG Dengue 2, fragment 3 amplification 
CGATATGGGTTATTGGATAGAAAGTG Dengue 2, fragment 4 amplification 
GTTGGTTCTTGAAAGGGTTGTTAGA Dengue 2, fragment 4 amplification 
CCTCACAGCAGAAAGCGGA Dengue 2, fragment 5 amplification 
GACTATGGCCGGAAGGTATCTCT Dengue 2, fragment 5 amplification 
CAATCCAGAGATCGAAGATGACA Dengue 2, fragment 6 amplification 
GCCTTCAGCTGCCACTCTGT Dengue 2, fragment 6 amplification 
CAGAGCGTGAAAAGGTGGATG Dengue 2, fragment 7 amplification 
GAGCTGCTGTGAGAGTTATGGGGT Dengue 2, fragment 7 amplification 
GTTAATGGGTCTTGGGAAAGGA Dengue 2, fragment 8 amplification 
GGCTCCTCCATATTTCCTTTGTAGT Dengue 2, fragment 8 amplification 
CCCAATTTTGCATAAAGGTTCTCA Dengue 2, fragment 9 amplification 
CTTCTAGTGTGATTCTTGTGTCCCA Dengue 2, fragment 9 amplification 
CTTGAGTGGAGTGGAAGGAGAAG Dengue 2, fragment 10 amplification 
CCCAATCAATGAGCCGCA Dengue 2, fragment 10 amplification 
GGAACAGGGTGTGGATTCAAGA Dengue 2, fragment 11 amplification 
AGAACCTGTTGATTCAACAGCACCA Dengue 2, fragment 11 amplification 
GGACGAGAAGGACGGTGAGA JN132154, A. albopictus hsp70, QPCR 
GCACAGCGCGGTTGTCCT JN132154, A. albopictus hsp70, QPCR 
GACGGCGGCATTGGCA 
XM_019672019, A. albopictus hsp70-like, 
QPCR 
CCGCTCGGCATTGGTGA 
XM_019672019, A. albopictus hsp70-like, 
QPCR 
CGCCGGCCCACCTGAT AAEL012532 QPCR and RNAi analysis 
GAGTTCGGCGAACCATCTCCT AAEL012532 QPCR and RNAi analysis 
CGCCGGCCCACCTGCT AALF02630 QPCR 
GATATTAATCATAGCGGTGCTCTCCT AALF02630 QPCR 
CCAGATCTGACCGGAACGACCTCAACA AAEL012532 dsRNA fragment cloning 
CGGGTACCCATGGCGGTGCTTTCCTTGA AAEL012532 dsRNA fragment cloning 





This study has established that dengue virus is able to use extracellular vesicles 
as vehicles for transmitting itself from infected mosquito cells to various naïve recipient 
cells. Viruses other than DENV that are implicated in the use of EVs for transmission 
include the human immunodeficiency virus, hepatitis C virus and Langat virus 
(Ramakrishnaiah et al., 2013; Wiley and Gummuluru, 2006; Zhou et al., 2018). These 
evidences supported our hypothesis that dengue virus, which is a flavivirus with a 
positive-sense single stranded RNA genome might also be transmitted through similar 
mechanisms. The multiple pieces of evidence generated in this work are shown starting 
with Figure 3 & 5 that show A. albopictus cells (C6/36) can be infected with DENV2 & 3 
and that EVs isolated using techniques described in Figure 4, also carry the viral RNA 
and protein at different time points post infection. Figure 7 further provides evidence that 
the entire DENV2 genome is present in the EVs derived from infected C6/36 cells. The 
genomic RNA of flaviviruses is single-stranded, ∼11 kb in length and is infectious with 
positive polarity, encoding the viral proteins required for RNA replication (Apte-
Sengupta et al., 2014; Gritsun et al., 2014). The abundant amount of E-protein and viral 
RNA in C6/36 EVs in comparison with the cell lysates suggests package of higher 
amounts of viral molecules for transmission to human and other vertebrate host cells. 
The dissemination of infectious EVs within mosquitoes from hemolymph to the salivary 
glands and subsequently to the mosquito saliva may efficiently facilitate the 
transmission of the infectious viral RNA and proteins to the vertebrate host through an 
infected mosquito bite during blood feeding. These data suggest that the full-length 
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genomes of other serotypes of DENVs and perhaps related flavivirus genomes are 
contained in arthropod EVs for transmission. In addition, a previous study from the 
Sultana lab has shown that the tick-borne Langat virus and mosquito-borne West Nile 
Virus (other members of Flaviviridae) RNA and proteins are also contained inside 
Ixodes scapularis tick or mouse neuronal cell derived exosomes and that exosome-
mediated Langat virus and West Nile Virus transmission to recipient cells is through 
receptor-dependent endocytosis (Zhou et al., 2018). We hypothesize that the presence 
of DENV2/3 RNA and proteins inside EVs could facilitate the viruses to escape the 
host’s antibodies, immune cells and defense response. This could allow enhanced 
fusion of EVs with naïve recipient cells through clathrin-dependent, receptor-mediated 
endocytosis for the establishment of infection.  
In the multiple cryo-EM analyses (Figures 5 and 7), the presence of intact virions 
inside or outside the EVs was not detected. One of the reasons for this could be that all 
our analyses were performed 72 hpi. To make virus preparations, concentrated 
supernatants from longer times of infection (7–14 dpi) with higher titers (109 to 1012 
PFU/mL) and centrifugal forces of 200,000 × g have been used (Fragnoud et al., 2015) 
that are not similar to the one used for our EV preparations (Figure 4). To avoid longer 
incubation days and peak of infection resulting in cell death, we performed all our 
experiments at 72 hpi. It is possible that longer times of infection (days 7–14 pi) may 
reveal intact mature viruses in EVs. Mosquito cell-derived EVs were found to have a 
wide ranging size distribution, varying from diameters of 30–150 nm (exosomes) and 
sizes of 150–350 nm (microvesicles). The quantification of EVs using the cryo-EM 
microscopy data suggested a smaller number of microvesicles in the DENV2-infected 
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group compared with the number of EVs from the uninfected group (Figure 6). In 
addition, the infected samples had an abundance of smaller EVs or exosomes of 0-100 
nm size. The DG-EVs isolation showed the presence of HSP70, an EV-enriched/ 
marker protein confirming the presence of EVs. Detection of DENV2 E-protein in denser 
fractions, along with HSP70 shows that the EVs, with size ranges of 50–100 nm carry 
the highest amount of viral E-protein (Tauro et al., 2012).  
Higher expression of HSP70 in infected samples could be due to the fact that EV 
marker presence has been correlated with a general increase in vesicle secretion, or 
rather with an increase in biomarker density on the surface of vesicles (Figure 5) (Chia 
et al., 2017; Rupert et al., 2017). The reference to the total protein concentration 
(determined by the BCA technique) each time has given us very reliable and consistent 
results with the routine isolation of EVs (Figure 6). Negligible differences in the viral 
loads in the 4G2 antibody-bead binding assay (Figure 8) suggests that E-protein is 
contained exclusively inside the EVs. If E-protein or viral particles were present outside 
the EVs as contaminants, the 4G2 antibody would bind E-protein, resulting in lower viral 
loads in comparison with the isotype antibody-treated or untreated controls. Treatment 
of DENV2 viral stocks with 4G2 antibody showed binding of surface-exposed E-protein, 
but not in the EV group, as E-protein was contained in the lumen of EVs and hence was 
unavailable to bind to the 4G2 antibody. RNase A-treatment assays were in agreement 
with the antibody-bead binding assay that further suggests no viral RNA was bound to 
the exterior of the EVs or was not present as a contaminant in our EV preps. If viral 
RNA was present in PBS suspensions containing EVs, we should expect an enhanced 
viral load in samples not treated with RNase A in comparison with the treated group. 
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These data are further supported by native-PAGE immunoblotting with 4G2 antibody 
and ELISAs that showed more intense signal in the Triton X-100 detergent–treated 
group in comparison with the untreated controls. Native-PAGE analysis indicated 
detection of either higher complexes of E-protein as dimer or oligomers or perhaps the 
presence of viral polyprotein (at higher molecular mass) under non-reducing conditions 
and in the native state. The observation of lower molecular mass of E-protein upon 
Triton X-100 treatment is possibly due to breakdown of the viral polyprotein.  
Figure 9 and 10 firmly establish that EVs derived from infected mosquito cells 
infectious, confirming the observations in a recent publication from Dr. Sultana’s 
laboratory (Zhou et al., 2018).  Naïve recipient cells exposed to EVs in contrast with the 
EDS showed a much higher load of dengue indicating that the majority of the infectious 
agents are contained within the EVs at 72 hpi. These data show that mosquito derived 
infectious EVs are able to establish infection in cells that they would encounter during 
the early stages during an in vivo infection of a vertebrate host i.e. human skin 
keratinocytes, murine dendritic cells as well as human vascular endothelial cells. 
Perhaps the viruses quickly insert their genome through EVs in the early stages of the 
infection and then when it has enough copies, the viremia with detectable mature virions 
occurs at later stages.  
To identify a molecular player facilitating receptor-mediated endocytosis of 
infectious EVs, we first looked at some EV markers. Starting with HSPs which include 
both constitutive and stress-inducible members that interact with native and denatured 
proteins to facilitate the proper folding of native proteins or refolding of the denatured 
proteins (Lancaster and Febbraio, 2005; Takeuchi et al., 2015). The presence of 
   
 
46 
mosquito HSP70s have been documented to increase during several environmental 
stresses, and several hsp genes are upregulated following a blood meal in mosquitoes 
(Benoit et al., 2010; Sanders et al., 2003). Upregulation of HSP70 homologs upon 
DENV2 infection suggested a protective role of this molecule during DENV2-induced 
stress. Figure 11 shows the presence of only one isoform (XM_019672019) of HSP70 in 
EVs suggesting its importance possibly in the chaperone activity inside EVs. The lack of 
any effect on DENV2 loads in EVs upon treatment with VER-155008 HSP70 inhibitor 
suggests that HSP70 is perhaps not required for DENV2 replication in cells and release 
into EVs. In addition, no differences in the DENV2 loads in naïve C6/36 cells upon 
treatment with infectious EVs derived from HSP70-inhibitor–treated and DENV2-
infected C6/36 cells suggests that HSP70 may not be required for EV-mediated 
transmission of DENV2 RNA and proteins. 
 We then identified another EV associated protein, the transmembrane/ 
tetraspanin domain containing glycoprotein Tsp29Fb in A. aegypti mosquito cells and 
EVs derived from both A. aegypti (Aag-2) and A. albopictus cells (C6/36) (Figure 12). 
Figure 13 shows the up-regulation of Tsp29Fb upon DENV2 infection at both 
transcriptional and translational levels, in vivo, in cells and EVs confirmed the link 
between this molecule and DENV2 infection in mosquitoes. Identification and 
characterization of this arthropod EV-enriched marker provides information on a 
molecular determinant that facilitates transmission of DENV2 from vector to the 
vertebrate host. Furthermore, the direct interaction and association of Tsp29Fb with 
DENV2 E-protein suggests a potential role of this molecule in mediating DENV2 entry, 
replication and transmission via the mosquito endo-exosome pathway. The enriched 
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signal for E-protein in both IP assays could be because of the abundance of Tsp29Fb to 
bind with DENV2 E-protein in cells compared with the EVs.  
Silencing of Tsp29Fb in Aag-2 cells showed a significant reduction in DENV2 
cellular loads and significantly reduced export of the viral RNA and E-protein in EVs 
(Figure 16). Functionally blocking of Tsp29Fb clearly showed reduced DENV2 loads in 
both EVs and C6/36 cells. These data clearly showed the prominence of this arthropod 
molecule in mediating DENV2 replication, release, and transmission via EVs. The use 
of exosome release inhibitor GW4869 at lower tested doses of 10–20 μM further 
confirmed that DENV2 transmission is mediated via EV release. The exosome inhibitor 
treatment significantly reduced the DENV2 capsid mRNA and E-protein. In addition, 
blocking of EVs/ exosome release by GW4869 reduced the infectious viral RNA and 
protein transport, thereby dramatically blocking the transmission to human blood 
endothelial cells. The direct interaction of the viral E-protein with Tsp29Fb was also 
affected by treatment with GW4869, suggesting a role for this arthropod marker in the 
EVs/ exosome release pathway. It would be an interesting future avenue to investigate 
the mechanism of this viral inhibition through blocking the release of EVs from arthropod 
saliva. The finding that inhibition of EVs/ exosome release/ exocytosis upon GW4869 
treatment in arthropod cells suggests the presence of neutral sphingomyelinase in 
mosquitoes.  
 Overall, this study suggests that inhibition of mosquito tetraspanin domain-
containing glycoprotein Tsp29Fb or inhibition of EV/ exosome release through the 
GW4869 inhibitor treatment can both be potential therapeutics to block transmission of 
DENV2 and perhaps other mosquito-borne flaviviruses.  
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METHODS AND MATERIALS 
 
Cell Culture and Infection of In Vitro Cell Lines  
           Aedes albopictus (C6/36 cells) and Aedes aegypti (Aag-2) cell lines were grown 
in either MEM medium or in Schneider’s insect medium with 10% FBS, respectively. 
Vero and HaCaT cells were grown in complete DMEM medium containing 10% heat-
inactivated FBS. Mouse monocyte-derived dendritic cells isolated from bone marrows of 
C57BL/6 wild-type mice were plated in RPMI medium containing 10% FBS and 10 
ng/mL of GM-CSF (Peprotech). Four days later, cells were re-plated in the same 
medium for experiments. HUVEC cells were grown in human lung MVEC medium 
(M199 medium; SIGMA, containing 150 mg ECGF- bovine brain extract and 20% FBS) 
and as per the instructions from Dr. Catravas laboratory. All culture medium and 
required supplements were purchased from Invitrogen/ThermoScientific Inc.   
 To determine infection, 1 x 105 of C6/36 or Vero or mouse-DCs or 
HaCaT/HUVEC cells were seeded in 12-well plates, infected with Multiplicity Of 
Infection (MOI 5) of DENV2 (TVP2176 provided by Dr John Anderson and New Guinea 
C strain) or DENV3 (DENV-3/US/BID-V1619/2005). Cells were collected at different 
time points (24, 48, 72 and 96 hpi) and processed for RNA extraction. Briefly, for re-
infection experiments with EV fractions containing infectious DENV2 RNA and proteins, 
1 x 105 C6/36 cells or HaCaT/HUVEC cells or mouse dendritic cells were co-incubated 
with 25 µL of mosquito cell-derived EV fractions (that corresponds to 126 µg of total EV 
protein as estimated by Bradford assay). We used 625 µL (same ratio) of EV depleted 
supernatant (EDS) fraction from C6/36 cells (collected from the step before PBS 
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washes during EV isolation, See Figure 4B). For re-infection studies, mosquito or 
mammalian cells (infected via EVs or EDS fractions collected from 72 hpi. DENV2- 
infected C6/36 cells) were collected at 72 hpi, and processed for RNA extractions. The 
IBC number for the all the cell culture performed for this study is 15-014. 
 
Cryo-Electron Microscopy  
 Purified concentrated suspensions of EVs in PBS were vitrified on carbon holey 
film grids (R2x2 Quantifoil®; Micro Tools GmbH, Jena, Germany; or C-flat™, 
Protochips, Raleigh, North Carolina) and as previously described (Sherman et al., 2006, 
2009). EVs were applied to the holey films in a volume of ca. 3 µl, blotted with filter 
paper, and plunged into liquid ethane cooled in a liquid nitrogen bath. We used 
computerized Vitrobot plunger (FEI, Hillsboro, OR) for freezing. Frozen grids were 
stored under liquid Nitrogen and transferred to a cryo-specimen holder (70 deg. 626, 
Gatan, Inc., Pleasanton, CA, or 2550 Cryo-Tomography holder, E.A. Fischione 
Instruments, Inc., Export, PA) under liquid Nitrogen before loading into a JEOL 2200FS, 
or a JEOL 2100 electron microscopes (JEOL Ltd., 3-1-2 Musashino, Akishima, Tokyo 
196-8558, Japan). JEOL 2200FS was equipped with in-column energy filter (omega 
type) and a field emission gun (FEG); JEOL 2100 had a LaB6 filament, both were 
operating at 200 keV. Grids were maintained at near-liquid Nitrogen temperature (-172 
to -180°C) during imaging. Preliminary screening and imaging of EVs was done using a 
4k x 4k Gatan US4000 CCD camera (Gatan, Inc., Pleasanton, CA), and final imaging 
was done at indicated 40,000x magnification with a 5k x 4k Direct Electron Detector 
Camera (DE-20, Direct Electron, Inc., San Diego, CA) using a low-dose imaging 
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procedure. An in-column omega electron energy filter was used during imaging with a 
zero-loss electron energy peak selected with a 20 eV slit. Images were acquired with a 
ca. 20 electrons/Å2 dose; the pixel size corresponded to 1.5 Å on the specimen scale. 
We used a 2.0 – 2.3 µm defocus range for imaging. Individual EV images were acquired 
from three independent isolated batches. For quantitation of EV size ranges, we 
manually analyzed the sizes using scale bar from cryo-EM images and counted EVs of 
different sizes per image in each group.  Three independent estimations and counts 
were performed without any bias. Percentages (for size determination) were calculated 
based on the total number of EVs in each size range.  
 
OptiPrepTM Density Gradient EV (DG- EVs) Isolation  
 2 x 108 or 1 x 109 of C6/36 cells were infected with either 2 or 5 MOI of DENV2, 
respectively or were maintained as uninfected controls. The detailed protocol is shown 
in Figure 4A or described in (Zhou et al., 2018). Supernatants (20 mL) from 
uninfected/infected cells were collected and centrifuged at 4°C (480 x g followed by 
2000 x g for 10 min each to remove cell debris and dead cells). Cell culture 
supernatants were (either filtered through 0.22 µm and then) concentrated to 2 mL 
using the Corning Spin-X UF concentrators or centrifugal filter device with a 5 k nominal 
molecular weight limit (NMWL). 15 mL volume of discontinuous gradient of 40% (w/v), 
20% (w/v), 10% (w/v) and 5% (w/v) solutions of iodixanol was prepared from the stock 
solution of OptiPrepTM 60% (w/v) of aqueous iodixanol (Axis-Shield PoC, Norway) with 
0.25 M Sucrose/10 mM Tris, pH 7.5. Polycarbonate bottles were loaded with 
discontinuous gradient of iodixanol (4 mL each of 40% (w/v), 20% (w/v), 10% (w/v) and 
   
 
51 
3 mL of 5% (w/v) from bottom to top).  Concentrated cell culture supernatants (1-2 mL) 
were overlaid onto the top of the gradient, and centrifuged at 100,000 x g for 18 h at 
4°C. Either 6 or 12 (12 in case of 0.22 µm filtered group) individual uninfected or 
infected fractions of ~2.6 mL or 1.3 mL (filtered) were collected (from top to bottom) 
manually (with increasing density of iodixanol) and diluted with 5 mL of sterile PBS. 
Fractions were centrifuged at 100,000 x g for 3 h at 4°C, followed by another PBS wash 
and spin at similar centrifugal forces. DG-EVs fractions were resuspended in 100 µL of 
PBS and stored at -80°C until further analysis. For cryo-EM images obtained from 
different fractions, EVs were isolated from DENV2-infected (MOI 5, 72 hpi) C6/36 cells 
(2 x 109) and samples were immediately shipped on dry ice to imaging facility. Similar 
processing methods were used to collect images from each fraction. 
 
Isolation of EVs from Cell Culture Supernatants  
 EVs were also isolated by differential ultracentrifugation method (Tauro et al., 
2012; Théry et al., 2006; Zhou et al., 2018). EVs isolation procedure and modifications 
are schematically shown in Figure 4B and respective figure legend. Briefly, 2 x 106 
C6/36 or 1 x 106 Aag-2 cells were seeded for EVs isolation in respective medium for 
overnight. Next day, cells were changed to respective medium containing bovine 
exosome-free FBS (Systems Biosciences Inc; SBI). After 4-5 hour of medium 
replacement, cells were infected with DENV2 (MOI 5). Cell culture supernatants were 
spun as shown in Figure 4B. Increased centrifugation times and rotor types are shown 
to improve EVs yield and purity (Cvjetkovic et al., 2014) and, hence were used for 
isolation of EVs from mosquito cells. Supernatants were spun at 100,000 x g, for 155 
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min. Supernatants collected after this spin served as EVs depleted supernatant (EDS) 
fractions (used as controls in our study and indicated with asterisk in Figure 4B). The 
pellet containing EVs and any contaminants were washed with ice-cold PBS and spin at 
100,000 x g, for another 155 min. Resulting EVs pellet is referred as EVs fraction in this 
study. Freshly prepared EVs pellets were resuspended in PBS and stored frozen at -
80°C for subsequent evaluations and assays or were directly resuspended in RNA lysis 
buffer (Bio-Rad) or modified RIPA buffer (G-Biosciences, BioExpress) for total RNA or 
protein extractions, or were immediately used in RNaseA and Triton-X-100 treatment 
studies, respectively. We also isolated EVs from mosquito cells using the commercial 
total EVs isolation reagent and extracted total RNA and proteins using total EVs RNA 
and Protein Isolation kit (Invitrogen/ThermoScientific Inc.) and as per the manufacturer’s 
instructions.  
 
PCR-Amplification of Full Length DENV2 Genome  
 The cDNA generated from total RNA isolated from C6/36 cell derived EVs was 
used as template for the amplification of DENV2 genome. The oligonucleotides used for 
the amplification are shown in Table 1. We amplified fragments 1-10 of variable sizes by 
regular PCR and fragment 11 (3’ end) by touchdown PCR. Regular PCR was performed 
with the following conditions: Initial denaturation at 95 ºC for 4 min followed by 40 cycles 
of steps including 95 ºC for 10s, 58ºC for 20s, and 72ºC for 1min. Fragments 1-10, 
amplified products of following sizes 1102 bp, 1110 bp, 1124 bp, 1114 bp, 1118 bp, 
1141 bp, 1104 bp, 1135 bp, 1110 bp and 1048 bp, respectively (Figure 7A). The 
fragment 11 amplified a product of 717 bp by touchdown PCR, performed with method 
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as described (Korbie and Mattick, 2008) . The PCR reactions were later run on 1% 
agarose gels, imaged using the Chemidoc MP imaging system, and processed using 
Image Lab software obtained from the manufacturer (Bio-Rad). 
 
RNA Extraction, cDNA Synthesis, and qRT-PCR Analysis  
 RNA from mosquito - C6/36 cells and Aag-2 cells, mouse monocyte-derived 
dendritic cells, HaCaT cells, Vero and HUVEC cells infected with various MOI of DENV2 
or uninfected controls at indicated time-points pi, was extracted using Aurum Total RNA 
Mini kit (Bio-Rad) and following manufacturer’s instructions. RNA was converted to 
cDNA using the Bio-Rad iScript cDNA synthesis kit. The generated cDNA was used as 
template for the amplification and determination of the viral burden. For detection of 
DENV2 RNA, published forward and reverse primers for dengue virus (Serotype 2) 
were used (Sultana et al., 2009). For DENV3 RNA detection, we used specific primers 
designed for Serotype 3, shown in Table 1. To normalize the amount of templates, 
either mosquito or mouse or human beta actin amplicon were quantified with published 
primers (Sultana et al., 2010, 2012). Primers for beta-actin were used in parallel for 
qRT-PCR normalization. Equal amounts of mosquito or mouse or human cDNA 
samples were used in parallel for beta actin and DENV2 capsid gene.  
 The ratio of DENV2 capsid gene copy/beta actin gene copy was used as an 
index to determine the rate of infection in each analyzed sample. In some experiments, 
with undetectable amounts of actin in EVs samples, we normalized to the total RNA 
loads. QRT-PCR was performed using iQ-SYBR Green Supermix (Bio-Rad, USA). 
Standard curves were prepared using 10-fold serial dilutions starting from standard 1 to 
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6 of known quantities of actin or DENV2 capsid gene fragments and qRT-PCR reactions 
were performed as described (Sultana et al., 2009, 2010, 2012). Primer sequences for 
all mosquito genes (including both hsp70 isoforms, tsp29Fb and actin) used in this 
study are provided in Table 1. For RNase A treatment, we isolated fresh EVs from either 
uninfected or DENV2-infected C6/36 cells (2 x 106), distributed the infected EVs as 
treated (5 µg/mL RNase A, 37°C for 15 min) or untreated groups. For laboratory virus 
stocks (generated by collecting cell culture supernatants from 14 days post infection 
C6/36 cells and held as frozen stocks), similar treatments with RNase A were performed 
on DENV2 (5 MOI). Naïve C6/36 cells (2 x 105) were infected (72 hpi) and either treated 
or untreated DENV2-infected EVs samples (25 µL) were processed for RNA extraction 
and qRT-PCR analysis. Untreated EV samples from uninfected group served as internal 
controls. 
 
Protein Estimation and Immunoblotting  
 2 x 106 of C6/36 or Aag-2 cells was seeded in six well dishes/plates for overnight. 
Next day, we changed the media containing bovine EVs free FBS (Systems 
BioSciences Inc.; SBI). After 4-6 hours of media replacement, cells were infected with 
DENV2/DENV3 (MOI 5). For EVs quantitation assay, C6/36 cells were plated in six well 
plates at densities of 104, 105, 106, 107, and 108 and followed by infection with DENV2 
(MOI 5, 72 hpi). Uninfected cells plated with similar densities were used as controls for 
estimation of total number of EVs. Cell culture supernatants were collected (at 72 hpi) 
and processed for EV isolation. EV fractions were collected after PBS wash and the 
adherent cells collected from the same plates (washed twice with 1 x PBS), were all 
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resuspended in modified RIPA buffer.  Total protein amounts were estimated using 
Bradford assay (BCA kit from Pierce/ThermoScientific Inc.) as three replicates. Total 
cell and EV lysates (30 µg) were separated on 12% or 4-20% SDS-PAGE gradient 
stain-free gels (Bio-Rad or NuSep; BioExpress) or processed for Coomassie blue 
staining.  Followed by gel electrophoresis, blots were blocked in either 5% milk buffer or 
BSA and probed with either highly cross-reactive 4G2 monoclonal antibody (obtained 
from Dr. Michel Ledizet, L2 Diagnostics or Millipore, Sigma) to detect DENV2 or DENV3 
E-protein (obtained from BEI resources) or human CD63 (Santa Cruz Biotechnology, 
Inc.) or human HSP70 (Cell Signaling Technologies, Inc. or Bio-Rad) or monoclonal 
anti-DENV2 NS1 (Abcam) antibodies or actin monoclonal antibody (Abcam), followed 
by mouse or rabbit monoclonal HRP-conjugated secondary antibodies (Santa Cruz 
Technologies, Inc.), respectively. Total protein profiles were images obtained from 
either stain free gels, Coomassie stained gels, or Ponceau S stained blots that served 
as loading controls. Antibody binding was detected with WesternBright ECL kit 
(Advansta, BioExpress/VWR). Blots were imaged using Chemidoc MP imaging system 
and processed using Image Lab software obtained from the manufacturer (Bio-Rad). 
 
E-Protein-Antibody-Beads Binding Assays  
 Freshly isolated EVs from 2 x 106 C6/36 cells (infected with MOI 5) were seeded 
on plates for overnight incubation, changed to exosome-free FBS medium after 4h, 
followed by infection with DENV2 for 72 hpi. EVs collected were resuspended in PBS 
and grouped into three categories as; untreated, treated with 4G2 antibody (that 
recognizes DENV2 E-protein) or relevant isotype control antibody (R & D Systems) 
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groups. In a similar way, we used DENV2 laboratory virus stocks (with known titers; 5 
MOI, suspended in MEM complete growth medium from C6/36 cells), also grouped as 
three categories (untreated, 4G2 or isotype antibodies treated, respectively). EVs 
fractions or DENV2 laboratory virus stocks were incubated for 1 h. (RT) with respective 
antibodies followed by incubation (4°C) with protein A/G agarose beads (Pierce/ 
ThermoScientific, Inc.) for another 30 min. The antibody-bead complexes were spun 
(13k rpm) at 4 °C for 30 min and supernatants were collected and lysed in RNA lysis 
buffer, processed for RNA extractions, followed by cDNA synthesis and qRT-PCR to 
analyze the DENV2 loads from either EVs samples or DENV2 laboratory viral stocks. 
 
Native-Poly Acrylamide Gel Electrophoresis (PAGE)  
 For this analysis, we seeded C6/36 cells (2 x 106) in complete MEM medium for 
overnight incubation, then replaced with exosome-free FBS medium followed by 
infection with DENV2 (MOI 5) for 72 hpi. Cell culture supernatants were processed for 
isolation of EVs (Figure 4B) and resuspended in PBS. EVs were separated as three 
groups (from the same preparations); group that was either held as untreated on ice, or 
group treated with Triton-X-100 (0.1%; 30 min, RT) or group treated with three cycles of 
freezing at -80°C (for 1 h.) followed by thawing at 4 °C. After treatments, protein lysates 
were prepared for non-reducing and non-denaturing sample conditions (62.5 mM Tris-
HCL, pH 6.8, 25% Glycerol and 1% Bromophenol blue) that maintained the proteins 
secondary structures and native charge density. Gels were pre-run for 60 min in gel 
running buffer (25 mM Tris and 192 mM Glycine). Uninfected or DENV2-infected EVs 
preparations with treatments or untreated samples were separated on 12% Native-
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PAGE gel, transferred on to nitrocellulose membrane, probed with 4G2 antibody 
followed by mouse monoclonal HRP-conjugated secondary antibody. Total protein 
profiles (Ponceau S stained image) served as loading control. WesternBright ECL kit 
(Advansta, BioExpress) detected antibody binding and blots were scanned using 
Chemidoc MP imaging system as described for immunoblotting analysis. 
 
Measurement of Relative Fluorescence  
 C6/36 cell-derived EVs (derived from 2 x 106 cells infected with DENV2 MOI 5; 
72 hpi) were resuspended in PBS (250 µL/sample). EVs were plated as five replicates 
of 50 µL each that corresponds to 254 µg of total EVs protein, as estimated by BCA 
method. EVs fractions held in PBS were either treated with 0.1% of Triton-X-100 for 30 
min or kept untreated. Samples were incubated with 4G2 monoclonal antibody (1:500 
dilution) for 1 h, followed by three times washes with PBS and secondary Alexa-Fluor 
594 mouse monoclonal secondary (1:2500 dilution) for 1 hour at RT. Relative 
fluorescence was measured using a Fluorimeter (Tecan, USA) with excitation at 590 nm 
and emission at 617 nm.  
 
Enzyme Linked Immunosorbent Assay  
 Freshly isolated mosquito cell-derived EVs (from 2 x 106 of DENV2-infected MOI 
5; 72 hpi cells) resuspended in PBS (250 µL/sample) were either treated with 0.1% of 
Triton-X-100 for 30 min or kept untreated. Nunc grade ELISA plates were coated with 
50 µL (that corresponds to 254 µg of total EVs protein as estimated by BCA method) of 
untreated or Triton-X-100 treated- uninfected or infected samples for overnight at 4 °C. 
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Samples were blocked with BSA and incubated with 4G2 antibody for 1 h, followed by 
HRP-conjugated mouse monoclonal secondary antibody for another 1 h for detection 
(Sultana et al., 2009). SureBlue TMB Microwell Peroxidase substrate and Stop solution 
(KPL) were used following manufacturer’s instructions. After stopping the reactions with 
TMB Stop solution, using a Multimode infinite M200 Pro Microplate reader (Tecan) 
optical density was measured from triplicate samples in two independent experiments 
and absorbance at 450 nm was recorded. 
 
Viral Immunofluorescence Assay  
 Dilution assays were performed as described in (Schoepp and Beaty, 1984). 
Briefly, C6/36 cells were seeded (at a density of 1 x 105 cells/well in 225 µL of MEM 
complete medium) into 96 well plates. Cells were incubated overnight and treated with 
either EVs fractions (20 µL; that corresponds to 101 µg of total EVs protein as estimated 
by the BCA method) or EVs depleted supernatant fractions (EDS; 675 µL) for 24 hours. 
Each of the group had six different dilutions (1-6) and at least 7-10 independent 
replicates in addition to the uninfected negative controls. Data is shown from dilution 1 
or 10 fold dilution (Figure 9A, 10A) or from dilution 3 or 1000 fold dilution (shown as 
Figure 9A). Cells were fixed with acetone-PBS mixture (3:1, for 20 min at -20º C) and 
plates were air dried, washed with 1 x PBS and blocked with 5% FBS-PBS-0.05% 
Sodium Azide for 15 min at RT. E-protein was detected by incubation with 4G2 antibody 
(for overnight at 4º C), followed by three washes with PBS. Samples were incubated 
with Alexa-594 labeled mouse secondary antibody for 1 hour at RT, followed by washes 
(3X) with PBS. Plates were analyzed using EVOS fluorescence system (Invitrogen or 
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ThermoScientific, Inc.) and cells were scored for fluorescence or the presence or 
absence of infection in comparison to the infected positive controls or uninfected 
negative controls. Representative images from dilutions 10-1 and 10-3 are shown. 
 
Plaque Formation Assays  
 Plaque assays were performed as described in (Sultana et al., 2009). EVs and 
EDS, were tested for infectious dose and capability of DENV2 viral RNA replication and 
formation of infectious plaques. Briefly, we seeded Vero cells in 6-well plates at 
densities of 2 x 106 cells per well, allowed them to adhere and grow as monolayers 
reaching 65-85% confluence (for ~24h.). EVs fractions containing unknown PFU 
(plaque forming units) of DENV2 viral genomes collected from C6/36 cells (5 x 106 cells; 
resuspended in 100 µL of PBS; 30 µL of this suspension) were used for plaque assays. 
EVs free supernatants (600 µL) corresponding to similar amounts of EVs fractions were 
used as controls.  Serial dilutions (1:10, 1:100 and 1:1000) of the EVs or EDS fractions 
were prepared in duplicate (from two independent experiments). Medium was removed 
4 hpi, and warm 2% Seaplaque agarose (Lonza) overlay with complete MEM media (1:1 
ratio) containing antibiotic and anti-mycotic solution (1% each; Sigma) was added. 
Plates were incubated for 6-7 days, at 37°C, 5% CO2. Plaques were stained with 0.03% 
Neutral Red (Sigma) for 4 h, and were counted on the same day or otherwise incubated 
(inverted and covered in foil) for overnight, and then plaques were counted to determine 
the viral titers during next day.   
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Immunoprecipitation Assays  
 Mosquito whole cell and EVs fractions were collected (either in RIPA modified 
protein lysis buffer containing protease and phosphatase inhibitors; SIGMA or in cold 1 
x PBS) from uninfected and DENV2 infected (MOI 5) cells (2 x 108 cells, 72 hpi). Before 
immunoprecipitation, lysates in RIPA buffer or samples resuspended in PBS were 
precleared with protein A/G agarose beads (Pierce/ ThermoScientific, Inc.) at a 1:10 
volume of 50% bead slurry and centrifuged at 12,000 rpm at 4ºC for 10 min. 
Supernatants were collected and protein concentrations were determined using the 
Bradford assay (BCA kit; Pierce/ ThermoScientific, Inc.). Samples were aliquoted as 
input (20 µg shown in total protein profile as controls) or used for immunoprecipitation 
(150-500 µg of lysates suspended in RIPA buffer or 500 µg of PBS suspended 
samples). Lysates/PBS suspended samples were incubated with 5 µg of highly cross-
reactive human CD63 antibody (Santa Cruz Biotechnology, Inc.) that recognizes the 
Tsp29Fb for overnight at 4ºC, followed by incubation with protein A/G agarose beads for 
4 h to complex with antibody. Samples were washed thrice with cold 1 x PBS and beads 
were resuspended in 40 µL of SDS sample Laemmeli buffer, boiled and loaded on 12% 
SDS-PAGE gels. Immuno-precipitates were further processed for immunoblotting (as 
described above) using the 4G2 antibody or actin monoclonal antibody (as control) to 
detect DENV2 E-protein or actin precipitation with Tsp29Fb.  
 
Immunofluorescence and Microscopy  
 1 x 105 C6/36 cells were plated on 18 mm coverslips in complete MEM medium 
and allowed to adhere for overnight. Cells were infected with DENV2 (MOI 2) for 72 hpi.  
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Uninfected and infected cells were fixed with 3.7% (wt. /vol.) paraformaldehyde (37ºC 
for 20 min), permeabilized with 0.2% (vol. / vol.) Triton X-100 (10 min at room 
temperature), and blocked with 3% bovine serum albumin (30 min at RT) in PBS, 
respectively. Cells were immuno-stained with antibodies directed against human CD63 
(that detect Tsp29Fb), or 4G2 (that detect DENV2 E-protein), and detected by anti- 
rabbit (human CD63) or mouse (4G2) secondary antibodies conjugated with Alexa Fluor 
488 or 594, respectively. Cells were counterstained for nuclei with DAPI and were 
detected below 300 nm wavelengths. Alexa Fluor conjugates and DAPI (obtained from 
Invitrogen/ ThermoScientific, Inc.). Images were obtained using the EVOS Fluorescence 
System (Invitrogen/ ThermoScientific, Inc.). Representative images are shown for co-
association between Tsp29Fb and DENV2 E-protein. 
 
RNAi, dsRNA Synthesis and Transfections  
 A. aegypti Mosquito cDNA was used as template to amplify the DNA encoding a 
fragment of Aedes tsp29Fb (Accession Number AAEL012532). Gene specific primers 
containing the BglII and KpnI restriction enzyme sites used in the PCRs are shown in 
Table 1. The amplified Aedes tsp29Fb fragment was purified by gel extraction (Using 
Qiagen kit) and cloned into the BglII and KpnI sites of the L4440 double T7 Script II 
vector (Sultana et al., 2010). Escherichia coli DH5alpha strain was used as a cloning 
host. Using the MEGAscript RNAi kit (Applied Biosystems/ ThermoScientific) and user 
manual instructions, we synthesized the dsRNA complementary to the Aedes tsp29Fb 
sequence. For dsRNA transfections and silencing of Tsp29Fb, we plated 1 x 106 of Aag-
2 cells in complete medium (Schneider medium with 10% FBS and L-glutamine), 
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allowed to adhere overnight, and used Lipofectamine transfections reagent (Invitrogen/ 
ThermoScientific). 750 ng of dsRNA mixed with Lipofectamine reagent was added on to 
cells and 6 hours post addition, 2x complete medium was added and plates were further 
incubated for additional 16 h. Cells were infected with DENV2 (MOI 2) and collected at 
24 hpi for further analysis. Silencing efficiency of tsp29Fb was analyzed by qRT-PCR 
and primers used are shown in Table 1.  
 
Inhibition Studies  
 For inhibition of HSP70, we used the commercially available inhibitor VER-
155008 (obtained from SIGMA-Aldrich), a small molecule ATP-derivative inhibitor of 
HSP70 (Lancaster and Febbraio, 2005; Takeuchi et al., 2015b). First we examined the 
cytotoxic effects of the VER-155008 inhibitor and found no changes at the tested doses 
of 10 and 20 µM, in comparison to the untreated group. C6/36 cells (2 x 106) were 
plated in 6 well plates and treated with VER-155008 inhibitor for 4 h. (at tested doses of 
10 and 20 µM) and followed by DENV2-infection (5 MOI) for 72 hpi. DMSO vehicle was 
used as mock control as VER-155008 was dissolved in DMSO. Cell supernatants were 
collected and processed for EVs isolation. Both cells and EVs were processed for RNA 
extractions followed by qRT-PCR to detect hsp70 expression or DENV2 loads. For re-
infection studies, we used EVs derived from VER-155008 inhibitor treated (for 4 h), 
followed by DENV2-infected (MOI 5, 72 hpi) C6/36 cells. EDS fractions (used in similar 
dilution to the use of suspended EVs per reaction) collected during EVs isolation (after 
pelleting of EVs) served as control. Fresh C6/36 cells were incubated (re-infection) with 
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either EVs (derived from VER-155008 treated and DENV2 infected C6/36 cells) or EDS 
fractions as controls.  
 For EVs inhibition studies, we used either the highly cross-reactive human CD63 
antibody or GW4869, a cell permeable and selective commercial inhibitor for Neutral 
Sphingomyelinase (N-SMase) (Santa Cruz Biotechnologies, Inc.) dissolved in DMSO. 
For the inhibitor and antibody studies, EVs were isolated using the isolation reagent 
(Invitrogen/ThermoScientific, Inc.). For antibody functional blocking studies, we treated 
C6/36 cells (2 x 105) for 2 h with either 5 or 10 µg of CD63 antibody, followed by DENV2 
infection (2 MOI) for 72 hpi. The untreated cells were used as controls. Cytotoxicity of 
the inhibitor was first analyzed and cells did not show any toxicity at tested doses (1-20 
µM). For the inhibitor studies, C6/36 cells (2 x 105) were plated in complete MEM 
medium for overnight, changed to exosome-free FBS medium for 4 h and then treated 
with the GW4869 inhibitor (with doses of 5, 10 15 or 20 µM) for another 4 h, followed by 
DENV2 infection (2 MOI) for 72 hpi (in case of qRT-PCR analysis) or for 18 or 24 hpi, 
for immunoblotting analysis.  Cells were treated with similar volume of DMSO as control 
groups. For infection kinetics using incubations with infectious EVs, HaCaT cells (2 x 
105) were treated with DENV2-infected (2 MOI; 72 hpi) and 15 µM of inhibitor treated 2 
x 105 of C6/36 cell-derived EVs and respective DMSO vehicle. Viral loads were 
determined from HaCaT cells at 48 hpi by qRT-PCR analysis. For immunoprecipitation 
assay, 1 x 107 of C6/36 cells were plated in regular complete MEM medium for 
overnight, changed with exosome-free FBS medium for 4 h., treated with 15 µM inhibitor 
or respective volume of DMSO as control, followed by infection with DENV2 (5 MOI) for 
24 hpi. Cell culture supernatants were processed for EVs isolation and whole cells and 
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EVs lysates (500 µg) were processed for immunoprecipitation with human CD63 
antibody, followed by immunoblotting with 4G2 antibody to detect viral E-protein. 
 
Transwell Assays  
 Transwell assays were performed to analyze the migration of infectious EVs 
released from infected C6/36 cells (seeded in inserts; upper chamber) to uninfected/ 
naïve HUVEC cells seeded in 12-well plates (lower chamber). Sterile, polycarbonate 
tissue culture-treated transwell inserts (12 mm insert size) with 0.4 µm microporous 
membrane pore size were used in our assays (Corning/VWR). We plated, 2 x 105 C6/36 
cells in inserts (upper chamber) and 2 x 105 HUVEC cells in 12-well plates (lower 
chamber). Inserts with C6/36 cells were first kept in a separate 12-well plate containing 
0.5 mL (in order to keep microporous membranes moist/wet) of MEM medium. Inhibitor-
treated group in transwell assays was treated with 20 µM of GW4869 inhibitor, and at 
24 h post treatment, C6/36 cells were either infected with EVs containing DENV2 (25 µL 
of the EVs fraction, that corresponds to 126 µg of total EVs protein as estimated by BCA 
method, collected from independent batch of DENV2 (MOI 5; 72 hpi) infected C6/36 
cells) or with DENV2 from laboratory viral stocks (MOI 5) prepared from infected C6/36 
cell (14 days pi) culture supernatants. The laboratory viral stocks with known titers were 
included as internal controls. Twenty-four hours post-infection, inserts with C6/36 cells 
(with change of new media) were moved to 12-well plates containing uninfected or 
naïve HUVEC cells. EVs containing viral RNA and proteins produced from C6/36 cells 
were allowed to transmigrate and infect HUVEC cells (that were kept uninfected/naïve). 
After, 48 h post-incubation (with infected C6/36 cells released EVs from inserts/upper 
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chambers) HUVEC cells from lower chamber were washed twice with ice-cold PBS and 
collected for RNA extractions, cDNA synthesis, and qRT-PCR to determine viral loads 
from HUVEC cells.  
 
Statistics  
 Statistical significance of difference observed in data sets was analyzed using 
GraphPad Prism6 software and Microsoft Excel. The non-paired, two-tailed Student t 
test was performed (for data to compare two means) for the entire analysis. Error bars 
represent mean (+SD) values, p values of < 0.05 were considered significant in all 
analysis. Statistical test and p values are indicated for significance. 
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IXODES SCAPULARIS HSP70 IS RESPONSIBLE FOR VARIABLE 





Ixodes scapularis ticks are hard-bodied, obligate hematophagous arthropods. 
These ectoparasites during the process of taking a blood meal can transmit many 
pathogens to the host (Anderson and Magnarelli, 2008). Understanding molecular 
interactions at the tick-host interface involve knowledge of the participation of host 
defense mechanisms against tick infestations and counter measures employed by ticks 
(Wikel, 2013). Tick feeding, egg production and viability affecting vector competence 
can be influenced and modulated by the acquired resistance by the host through both 
humoral and cellular immuno-regulatory pathways (Brossard and Wikel, 2004). Ticks 
have many strategies for successfully avoiding the host response too. It involves the 
suppression of the host’s antibody production, complement activation and cytokine 
production from both antigen-presenting cells and T cells (Brossard and Wikel, 2004; 
Francischetti et al., 2009; Hovius et al., 2008). Ixodes scapularis ticks have been known 
to transmit pathogens like Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia 
microti, Ehrlichia muris-like agent, Powassan virus and B. miyamotoi. The cause Lyme 
disease, human anaplasmosis, babesiosis, human ehrlichiosis, encephalitis and 
relapsing fever respectively (Anderson and Armstrong, 2012; Anderson and Magnarelli, 
2008; Krause et al., 2014; Pritt et al., 2011).  
To establish a successful feeding niche, commence blood feeding and 
engorgement  to repletion, I. scapularis ticks secrete a range of molecules through their 
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saliva responsible for anti-hemostatic, anti-inflammatory, immunosuppressive and 
immune-modulators against the host’s immunity pathways (Brossard and Wikel, 2004; 
Hovius et al., 2008; Ribeiro and Francischetti, 2003; Wikel, 2013). Tick-borne 
pathogens exploit these molecules present in tick saliva to enhance their ability to 
transmit themselves and infect vertebrate hosts (Jones et al., 1989; Kročová et al., 
2003; Labuda et al., 1993). Many studies have explored the role of pathogens in the  
modulation of tick gene expression (Neelakanta et al., 2010; Pal et al., 2004; Sultana et 
al., 2010). However, the influence of different genetic or immune backgrounds of the 
vertebrate hosts on tick biology and behavior during acquisition of a blood meal has not 
yet been fully evaluated. Previous studies have reported significant variations in many 
basic hematological and coagulation factors among many mouse strain backgrounds 
(Emeis et al., 2007; Peters et al., 2002). It also been recently shown that T-cells 
participate in coupling coagulation with inflammation implicating a direct role of host 
immune status with coagulation (Green et al., 2015). These studies provide a strong 
rationale to test whether different genetic or immune status of hosts influence feeding 
and gene expression in Ixodes scapularis ticks. The results presented in this study 
report that the host’s genetic background and/ or immune status does influence specific 
tick gene expression that subsequently impact variable fibrinogenolysis during feeding 
though the involvement of a tick HSP70-like molecule. 
  





Engorgement Weights Are Greater in Ticks Fed on Immunodeficient vs 
Immunocompetent Mice 
The first analysis was to determine if the immune status of hosts influence tick 
engorgement weights. Two sets of age and background matched immunocompetent 
(C57BL/6J and BALB/c) or immunodeficient (RAG-/- and SCID) mice with independent 
housing conditions were ordered from two different vendors. These mice were infested 
with uninfected I. scapularis larvae. After repletion, the engorgement weights of 
individual larvae were measured using an analytical balance. The post-feeding weight of 
larvae that fed on immunodeficient mice (0.499 ± 0.06 mg for RAG-/-; 0.517 ± 0.05 mg 
for SCID) was significantly (P < 0.05) higher in comparison to the larvae that fed on 
immunocompetent (0.479 ± 0.06 mg for C57BL/6J; 0.467 ± 0.06 mg for BALB/c) mice 
(Figure 17A & B).  
 
Presence of a Host Fibrin Degradation Product- D-Dimer Was Reduced in Ticks 
Fed on Immunodeficient Mice  
During feeding, ticks may acquire host proteins like fibrinogen and its 
degradation products along with the vertebrate blood (Villar et al., 2016). Hence, we 
decided to check for the presence of D-dimer, which is a degradation product of fibrin 
(Cesarman-Maus and Hajjar, 2005), in the lysates of whole ticks fed on immunodeficient 
vs. immunocompetent animals. The total protein profile of ticks that were fed on either 
group of mice did not show any significant difference (Figure 18A & B). Immunoblotting 
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showed negligible presence of D-dimer in the whole tick lysates obtained from ticks fed 
on immunodeficient mice in comparison to the respective control groups of ticks fed on 
immunocompetent animals (Figure 18C & D, respectively). Densitometry of the same 
immunoblots show that the difference in D-dimer presence is statistically significant (P < 
0.05) (Figure 18E & F). An independent experiment shown in Figure 19A-19C 
corroborated this data. Immunoblotting assays performed with purified D-dimer protein 
along with total lysates from ticks fed on immunocompetent mice validated that the 
observed band at size ~ 200 kDa in these samples is D-dimer which was found to be 
negligible in total lysates prepared from ticks fed on immunodeficient animals (Figure 
18G & H, and Figure 20A & B). Densitometry was performed as a graphical 
representation of the immunoblot analysis (Figure 18C and 19C). Taken together, these 
results show that there is a significant decrease in fibrinogen degradation at the bite site 
when ticks feed on immunodeficient animals. 
 
Salivary Gland Lysates Prepared from Ticks Fed on Immunodeficient Animals 
Show Reduced Fibrinogenolytic Activity In Vitro  
Next we tested whether salivary gland lysates prepared from nymphal ticks fed 
on immunodeficient animals show a decrease in fibrinogenolytic activity in vitro in 
comparison to salivary gland lysates prepared from nymphs that fed on 
immunocompetent animals. Immunocompetent and immunodeficient mice were infested 
with nymphs. The nymphs were collected upon repletion and were processed for 
salivary gland isolation. Purified fibrinogen was incubated with the salivary gland lysates 
over time. The sample when subjected to PAGE showed a reduction in the degradation 
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of Aα chain of fibrinogen in the presence of CaCl2 at 2 and 4 hours post-incubation vs. 
the salivary gland lysates prepared from nymphs fed on immunocompetent animals 
(Figure 21A & B). Densitometry was performed to graphically represent this observation 
(Figure 21C & D). The salivary gland lysates prepared from nymphs fed on 
immunocompetent mice showed increased degradation of Aα chain of fibrinogen in the 
presence of CaCl2 even at shorter incubation times of 15 and 30 min in vs. salivary 
gland lysates from nymphs fed on immunodeficient mice as shown in Figure 22. The 
degradation of fibrinogen Aα chain (in all cases) was abrogated in the presence of 
EDTA. Increased fibrinogenolytic activity was observed with the salivary gland lysates 
prepared from ticks fed on BALB/c mice even upon exposure to EDTA (Figure 21F & 
H). CaCl2 or EDTA did not result in any degradation of fibrinogen as seen in Figure 23. 
The salivary gland lysates used in the fibrinogenolysis assay by themselves did not 
show any prominent bands that coincided with the size of the fibrinogen (Figure 21).  
 
The Expression of the Tested Metalloprotease Genes Did Not Show Any 
Alteration in Ticks That Fed on Immunocompetent Mice vs Immunodeficient Mice  
 A tick metalloprotease belonging to reprolysin family containing pre- and pro-
enzyme domains, zinc-binding motif and cysteine-rich region from salivary glands of I. 
scapularis has been suggested to participate in fibrinogenolytic activities (Francischetti 
et al., 2003). Therefore, we analyzed expression of four tick metalloproteases (GenBank 
acc. nos. XM_002416249, XM_002416250 and XM_002412196) along with the salivary 
gland metalloprotease (GenBank acc. no. AY264367) that was previously suggested to 
participate in fibrinogenolysis (Francischetti et al., 2003). QRT-PCR analysis revealed 
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that the expression of the tested metalloproteases did not show significant (p > 0.05) 
difference in expression between ticks that were fed on immunocompetent or 
immunodeficient animals (Figure 24A-D). 
 
LC-MS/MS Based Identification of Proteins Showing Differential Expression in the 
Salivary Glands of Ticks Fed on Immunocompetent vs Immunodeficient Mice 
A 1-D PAGE with the salivary gland lysates prepared from ticks fed on 
immunocompetent or immunodeficient animals was performed (Figure 25A). A band 
showing increased intensity at ~ 100 kDa in the salivary glands of ticks fed on C57BL/6J 
mice was chosen for further analysis (Figure 25A and Figure 26A & B). Similar results 
were obtained for the ~ 100 kDa band in the salivary gland lysates prepared from ticks 
fed on BALB/c mice in comparison to salivary gland lysates prepared from ticks fed on 
SCID mice (Figure 26C and D). Since the ~ 100 kDa band was upregulated in both sets 
of immunocompetent mice, this band was excised from the C57BL/6J fed tick samples 
and subjected to LC-MS/MS analysis. The result revealed higher peptide matches for 
tick HSP70-like proteins (Table 2, Figure 27A & B). The LC-MS/MS experimental 
procedures were performed by our collaborator Dr. Sucharita Dutta. 
 
One Isoform of the Tick HSP70-Like Molecules is Upregulated in Nymphs Fed on 
Immunocompetent Animals vs Immunodeficient Animals  
QRT-PCR analysis was performed with the samples generated from whole 
larvae fed on C57BL/6J or RAG-/- mice for all six tick HSP70-like isoforms that were 
identified in LC-MS/ MS analysis (Table 2). The mRNA levels for five of the HSP70-like 
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genes (GenBank Acc. Nos. XM_002433611, XM_002407088, XM_002406516, 
XM_002415881, and XM_002402518) were found to be unchanged in larvae fed on 
either group of mice (Figure 25B-F). However, one of the HSP70-like molecules 
(GenBank Acc. No. XM_002412155) was found to be significantly (P < 0.05) 
upregulated in ticks fed on immunocompetent mice in comparison to ticks fed on 
immunodeficient mice (Figure 25G). Alignment of the amino acid sequences of all 
HSP70-like molecules analyzed in this study using ClustalW program revealed a high 
degree of conservation across the entire sequence (Figure 28). The tick HSP70-like 
molecule (XM_002412200) corresponding to the nucleotide sequence (GenBank acc. 
no. XM_002412155) shares approximately 82, 47, 72, 81, 59% identity respectively with 
other tick HSP70-like molecules (GenBank acc. nos. XP-002406560, XP_002402562, 
XP_002407132, XP_002415926, XP_002433656) analyzed in this study (Figure 28). 
Mr. Vikas Taank (graduate student with Dr. Neelakanta) performed the qRT-PCR 
analysis for the HSP70- like tick genes, published in Vora et al., 2017. Taken together, 
the results from LC-MS/MS and qRT-PCR analysis provide important insights on the 
novel role for the participation of specific tick HSP70-like molecule in fibrinogenolysis 
during blood feeding.  
 
Treatment of Salivary Gland Lysates with VER-155008 (HSP70 inhibitor) or with 
Anti-HSP70 Antibody Resulted in Reduced Fibrinogenolytic Activity  
To validate whether HSP70-like molecules in ticks participate in fibrinogenolysis, 
salivary gland lysates prepared from ticks fed on C57BL/6J were incubated with VER-
155008 or with mock (DMSO). Salivary gland lysates treated with HSP70 inhibitor 
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showed reduced Aα chain degradation in comparison to the mock-treated lysates 
(Figure 29A & B). Similar assays were performed with salivary gland lysates prepared 
from ticks fed on C57BL/6J in the presence of anti-HSP70 antibody vs. isotype-matched 
antibody (Figure 29C). Salivary gland lysates treated with anti-HSP70 antibody showed 
reduced Aα chain degradation in comparison to the isotype-treated controls at 15 and 
30 min incubations (Figure 29C & D). Collectively, these results support a novel role for 
the participation of tick HSP70-like molecule in variable fibrinogenolysis during blood 
feeding on hosts with different immune backgrounds. 
Figure 17. Engorgement Weights of Ticks Increase upon Feeding on Immunodeficient Animals  
(A and B) Uninfected, unfed larvae were fed on gender and age matched immunocompetent mice 
(C57BL/6J, BALB/c) or immunodeficient (RAG-/-, SCID) mice. Data from C57BL/6J and RAG-/- and 
A B 
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BALB/c and SCID NCr mice is shown. In both sets, the weights are greater in ticks fed on 
immunodeficient mice vs. immunocompetent. Each circle represents one individual tick.  
Figure 18. Fibrin Degradation Product (D-dimer) Was Reduced in Ticks Fed on Immunodeficient 
Animals  
(A and B)The total protein profile from ticks fed on individual mice (3 mice/group) is shown.  
A B C D 
E F 
G H 
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(C and D) Immunoblotting performed with larval total lysates and anti-D-dimer antibody showed negligible 
or reduced D-dimer in ticks fed on immunodeficient animals vs. immunocompetent groups.  
(E and F) Densitometry analysis showing presence of D-dimer in C57BL/6J, RAG-/- samples and BALB/c, 
SCID samples relative to the respective bands seen in (A) and (B) (marked with asterisk).   
(G) Ponceau S stained membrane image showing D-dimer along with tick total lysates.  
(H) Immunoblotting assays with anti-D-dimer antibody show the presence of D-dimer in lysates prepared 
from ticks fed on immunocompetent animals at the same position (~ 200 kDa) as native D-dimer protein. 
Arrow next to the immunoblots (C, D & H) indicates position of D-dimer. 
Figure 19. Independent Experiment Showing Presence of D-Dimer in Ticks Fed on 
Immunocompetent Animals  
(A) 3-5 larvae fed on C57BL/6J or RAG-/- were pooled and total lysates were prepared. Total protein 
profile of the two samples are shown.  
(B) Immunoblotting performed with tick total lysates and anti-D-dimer antibody showed significantly 
reduced level of D-dimer in ticks fed on immunodeficient animals in comparison to ticks fed on 
immunocompetent animals.  
(C) Densitometry for the immunoblot shown in (B). D-dimer presence was calculated relative to the 
respective bands seen in (A) marked with asterisk. 
 
  
A B C 
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Figure 20. The Amount of D-Dimer is Reduced in Ticks Fed on Immunodeficient Animals  
(A) Inverted image or, 
(B) low intensity image for data in Figure 18H is shown. Immunoblotting with anti-D-dimer antibody 
showed presence of D-dimer in lysates prepared from ticks fed on immunocompetent animals (C57BL/6J, 
BALB/c) at the same position (~ 200 kDa) as native D-dimer protein. The arrow indicates position of D-
dimer.  
(C) Densitometry analysis for the immunoblot in B showing the level of D-dimer in ticks fed on 
immunocompetent or immunodeficient mice. The level of D-dimer for each sample was measured relative 
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Figure 21. Salivary Gland Lysates Prepared from Ticks Fed on Immunodeficient Animals Show 
Reduced In Vitro Fibrinogenolytic Activity  
(A and B) Purified fibrinogen was incubated with the salivary gland lysates for the indicated times (in 
hours) in the presence of 1 mM CaCl2 where there is increased fibrinogenolysis with time in 
immunocompetent samples vs. immunodeficient. Solid arrow indicates Aα chain of fibrinogen and dotted 
line indicates degradation product. 
(C and D) show densitometry of bands observed in (A and B). 
(E and F) Reactions incubated with 1 mM EDTA do not show any fibrinogenolysis or show abrogated 
fibrinogenolysis.  
(G and H) show densitometry of bands observed in (E and F).  
 
 
A C B 
D 
F E G 
H 
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Figure 22. Salivary Gland Lysates Prepared From Ticks Fed on Immunocompetent Animals Show 
Increased Fibrinogenolytic Activity Even at Early Time Points  
(A) Purified fibrinogen was incubated with tick salivary gland lysates for the indicated times (in minutes) in 
the presence of 1 mM CaCl2 or, 
(B) 1 mM EDTA showing similar results as Figure 21. 
 
 
Figure 23. Treatment of CaCl2 or EDTA Alone Had No effect on Fibrinogen Degradation  
SDS-PAGE analysis of salivary gland lysates prepared from ticks fed on immunocompetent or 
immunodeficient mice showed no prominent fibrinogen degradation products. Incubation of fibrinogen 
with CaCl2 or EDTA alone had no effect on fibrinogen degradation.  
Salivary gland lysate, fibrinogenolysis 
B A 




Figure 24. Expression of Metalloproteases is Unaltered in Ticks upon Feeding on 
Immunocompetent or Immunodeficient Animals  
(A, B, C and D) QRT-PCR results showing levels of four arthropod metalloproteases, GenBank acc. nos. 
AY264367 (A), XM_002416249 (B), XM-002416250 (C) and XM_002412196 (D), transcripts in ticks fed 
on immunocompetent (C57BL/6J) or immunodeficient (RAG-/-) animals. The mRNA levels for 
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Figure 25. Transcripts of Arthropod HSP70-Like Proteins are Downregulated in Immunodeficient 
Animals  
(A) 1-D SDS-PAGE profile in salivary glands of ticks fed on C57BL/6 J or RAG−/− mice is shown. Solid 
arrow indicates around 100 kDa band (that was excised and processed by LC-MS/MS analysis) and 
A 
B C D 
E F G 
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dotted arrow indicates another band around 73 kDa that were found to be upregulated in salivary gland 
lysates prepared from ticks fed on immunocompetent mice.  
(B, C, D, E, F and G) QRT-PCR results showing levels of XM_002433611 (B), XM_002407088 (C), 
XM_002406516 (D), XM_002415881 (E), XM_002402518 (F) and XM_002412155 (G) transcripts in ticks 
fed on immunocompetent or immunodeficient mice.  
(G) Transcript XM_00241255 was undetectable or had very low threshold levels in some of the ticks that 
were fed on immunodeficient animals.  
Each circle represents one tick. Student’s t test p values are shown. Mr. Vikas Taank performed the qRT-
PCR analysis for this figure. 
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Figure 26. SDS-PAGE Analysis of Total Protein Profiles in Ticks Fed on Immunocompetent or 
Immunodeficient Animals  
(A and B) Densitometry analysis for the SDS-PAGE gel image from Figure 25A showing levels of ~100 
kDa (A) and ~ 73 kDa (B) protein band in ticks fed on C57BL/6J or RAG-/- mice.  
(C) 1-D SDS-PAGE analysis of total protein profile in salivary glands of ticks fed on BALB/c or SCID is 
shown. Solid arrow indicates band around ~ 100 kDa that was upregulated in salivary gland lysates 
prepared from ticks fed on BALB/c mice in comparison to salivary gland lysates prepared from ticks fed 
on SCID mice.  
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Table 2. LC-MS/MS Data Showing Presence of Arthropod HSP70-Like Proteins in Salivary Gland 
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 Figure 27. Extracted Ion Chromatogram from LC-MS/MS Analysis  
(A) The Uniprot sequence for XM_002412155 identified in the MS analysis are colored in blue or red text. 
Orange triangles indicate oxidation sites and blue triangles indicate carbamidomethylation sites.  
(B) Extracted Ion Chromatograms for all identified peptides for Uniprot sequence (B7Q7S0) with 
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Figure 28. Alignment of I. scapularis HSP70-Like Molecules Identified from LC-MS/MS Analysis 
Amino acid sequence alignments were performed using Clustal W program in DNASTAR Lasergene. 
Residues that match are shaded as black color. The GenBank accession numbers for proteins 
XP_002412200, XP_002406560, XP_002402562, XP_002407132, XP_002415926 and XP_002433656 
corresponds to the nucleotide accession numbers XM_002412155, XM_002406516, XM_002402518, 
XM_002407088, XM_002415881 and XM_002433611, respectively. Percent identities for XP_002412200 
(GenBank nucleotide acc. no. XM_002412155) in comparison to other HSP70-like molecules are shown 
at the bottom of the alignment. 
B 
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Figure 29. Tick HSP70-Like Protein Participates in Variable Fibrinogenolysis  
(A) Fibrinogenolysis assays performed with salivary gland lysates prepared from ticks fed on 
immunocompetent animals in the presence of a HSP70 inhibitor or equal volume of mock control and 
incubated over time. Solid arrow indicates increased Aα chain fibrinogen degradation and dotted arrow 
indicates increased fibrinogen-degraded product at 30 min in mock control in comparison to inhibitor-
treated samples.  
(B) Densitometry analysis for data shown in (A).  
(C) Fibrinogenolysis performed with salivary gland lysates prepared from ticks fed on immunocompetent 
animals in the presence of anti-HSP70 antibody or an isotype control and incubated over time. Arrow 
indicates increased fibrinogen degradation in the presence of isotype-matched control antibody.  
(D) Densitometry analysis for data shown in (C).  









Acquiring a blood meal is a multi-step process for ticks. It involves attachment to 
the host, insertion of their proboscis, secretion of their saliva into the host’s dermis and 
blood stream, engorgement on host blood, and detachment after repletion. To 
accomplish this while evading detection and immune defense mechanisms, the ticks 
produce many tick molecules (Brossard and Wikel, 2004; Francischetti et al., 2009; 
Hovius et al., 2008; Ramos and Selistre-de-Araujo, 2006; Ribeiro and Francischetti, 
2003; Wikel, 2013). Fibrinogenolysis at the bite site is once such evasive mechanism 
elicited by ticks to achieve suppressed host coagulation. We report through this study a 
novel role for arthropod HSP70-like molecules in tick-induced fibrinogenolysis. The 
hypothesis is that the increase in post-engorgement weight of ticks fed on 
immunodeficient mice is due to reduced fibrin/fibrinogen clotting in these mice. The 
results show a lower expression of an hsp70-like molecule in ticks that fed on 
immunodeficient animals with respect to the immunocompetent cohort (Figure 25A and 
G). This is consistent with the reduced fibrinogen degradation around the tick bite site 
on these animals (Figure 18, 19, 20, 21 and 22). The increased transcriptional 
expression for only one of the HSP70-like molecule out of six molecules analyzed in this 
study does not rule out involvement of the other HSP70-like molecules at different 
stages of engorgement in ticks. The reduced presence of murine D-dimer in ticks fed on 
immunodeficient mice in comparison to ticks fed on immunocompetent mice strongly 
supports this hypothesis (Figure 18). Decreased fibrin/ fibrinogen clotting could account 
for higher blood in-take and weight of ticks fed on the immunodeficient animals (Figure 
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17) and possibly increased transmission of pathogens. The case for higher chance of 
pathogen transmission is supported by a study that has reported an increased rate of 
transmission of pathogens from ticks to immunodeficient animals in comparison to the 
immunocompetent animals (Bockenstedt et al., 2006).  
A previous study has shown that antibodies generated against recombinant 
Haemaphysalis longicornis HSP70 recognized bands at approximately 100, 72 and 28 
kDa in the egg lysates prepared from these ticks (Tian et al., 2011). This suggests that 
insects like Haemaphysalis longicornis or I. scapularis may be expressing a molecule 
similar to HSP70 but with a different size or that the tick HSP70-like molecules undergo 
several posttranslational modifications. HSP70s also form antiparallel dimers stabilized 
by post-translational modifications to position them for transfer to HSP90 (Morgner et 
al., 2015). Taken together, the observation of an HSP70-like peptide sequence 
recording the highest peptide match and scores in our LC-MS/MS analysis for a ~100 
kDa band is not surprising. 
From the works of Tytell and Hightower one can draw precedent that HSP70 
could transit through the extracellular spaces (Hightower and Guidon, 1989; Tytell et al., 
1986). Human serum contains significant amounts of HSP70s suggesting this 
molecules existence in extracellular spaces or as secreted proteins (Pockley et al., 
1998). This, in combination with evidence that a proteasome component Sec61p and 
HSP70 are involved in the degradation of fibrinogen in the mammalian cells (Xia and 
Redman, 2001) confirms our data in Figures 21, 22 and 29. These data provide the 
evidence that arthropod HSP70-like molecules play a role in fibrinogenolysis during tick 
blood feeding. The differential ex vivo fibrinogenolysis between salivary gland lysates 
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prepared from ticks fed on SCID and RAG−/− mice could be due to the two different 
genetic backgrounds (BALB/c and C57BL/6 J, respectively). They could also be due to 
the leakiness in the generation of some clones of T and B cells in the SCID mice. A role 
for five the other HSP70-like molecules in fibrinogenolysis cannot be excluded in ticks 
during feeding on diverse vertebrate hosts (deer, rabbits, birds…etc.). Future 
comparative studies on all tick HSP70-like molecules would reveal whether they have 
similar or redundant function during arthropod blood meals. VER155008 is an ATP-
competitive inhibitor and arrests the N-terminal domain of HSP70 that subsequently 
affects substrate binding (Schlecht et al., 2013). Figure 29 shows reduced 
fibrinogenolysis upon treatment of salivary glands lysates generated from ticks fed on 
immunocompetent animals with VER155008.  
This data suggests that the N-terminal domain of the tick HSP70-like protein is 
critical for recognition of its substrate proteins that are responsible for fibrinogen 
degradation. RAG−/− mice do not produce any mature T or B-lymphocytes and this is 
described as a “non-leaky” immune deficiency animal model while some SCID mice 
have a “leaky” mutation which leads to the development of a few clones of T and B cells 
(Bosma et al., 1988). T and B-cells play important roles in the host immune responses 
against tick bites (Anguita et al., 2002). The lack of T and B cells or other metabolites in 
the host blood could also account for increased blood in ticks fed on immunodeficient 
animals independent of the host blood clotting factors. Several studies have now 
characterized various tick salivary proteins involved in T and B cell inhibition (Anguita et 
al., 2002; Gillespie et al., 2001; Kotsyfakis et al., 2006). Further investigation is required 
to determine whether tick HSP70-like proteins affect activation of host T and B cells 
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facilitating arthropod blood feeding. The data showing a decreased fibrinogenolysis from 
salivary gland lysates prepared from ticks fed on T and B-cell deficient background host 
provides important future avenues in understanding the role of these cells in blood 
clotting during tick feeding. It also provides direction to discover their involvement in 
coagulation pathways around the feeding cavity formed by the arthropod bites.  
We further hypothesize that HSP70-like molecules secreted in tick saliva may aid 
in proper folding of proteins that are involved in fibrinogenolysis at the arthropod bite 
site to facilitate blood feeding. However, the contribution of arthropod HSP70 molecules 
to fibrinogenolysis either directly or indirectly would not rule out other salivary activities 
by these molecules important during feeding.   
In summary, using I. scapularis as a model, this study provides evidence that 
ticks elicit variable fibrinogenolysis upon feeding on hosts with different genetic 
background and/or immune status. This study is not only important in understanding the 
molecular basis of the interactions at the tick-host interface but may also potentially lead 
for the development of anti-tick vaccines to interfere with the life cycle of this and 
perhaps other medically important vectors. 
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METHODS AND MATERIALS 
 
Ticks and Mice  
 Laboratory-reared specimens of Ixodes scapularis ticks were used throughout 
this study. Ticks used in this study were larvae and nymphs obtained from a 
continuously maintained tick colony at the Department of Epidemiology and Public 
Health, Yale University (New Haven, CT) or at the Connecticut Agricultural Experiment 
Station (New Haven, CT).  All animal work in this study was carried out in strict 
accordance with the recommendations in the Guide for the Care and Use of Laboratory 
Animals of the National Institute of Health. The protocol (#16-017) approved by the Old 
Dominion University Institutional Animal Care and Use Committee (Animal Welfare 
Assurance Number: A3172-01) was used in this study. Animal husbandry was provided 
in accordance with criteria approved by the Association for Assessment and 
Accreditation of Laboratory Animal Care Program at ODU. Acepromazine (Phoenix, St. 
Joseph, Missouri) tranquilizer was administered to the animals prior to handling to 
minimize anxiety and/or discomfort and all efforts were made to minimize suffering. To 
generate fed larvae or nymphs, unfed ticks were allowed to feed on naïve 6-8 weeks 
C57BL/6J and B6.129S7-Rag1tm1Mom/J (RAG-/-) mice (Jackson laboratories) or BALB/c 
and SCID NCr (Charles River Laboratories) to repletion and were collected immediately 
after drop-off for tick weight measurements and RNA extractions. At least three mice 
per experimental group were used. For D-dimer immunoblotting assays, ticks that were 
collected from individual mouse were used for the analysis. For salivary gland lysates 
preparation, ticks were pooled from three mice and used for further analysis. Tick 
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rearing was conducted in a Parameter Generation and Control incubator (Black 
Mountain, North Carolina) at 23°C with 95% relative humidity and a 14/10 hour 
light/dark photoperiod regiment. The IBC number for this study are 15-012 and 15-013. 
 
Fibrinogenolysis Assays 
 The fibrinogen (2.5 mg/mL) purchased from Sigma (USA) was dissolved in 
solution with pH 7.4 containing 50 mM HEPES and 150 mM NaCl and distributed in two 
portions, one with 1 mM CaCl2 and the other with 1 mM EDTA. Five micrograms of 
salivary gland extracts were pre-incubated with 1 μL of 150 mM NaCl. The samples 
were incubated for 90 min.  In some cases, salivary gland lysates and 150 mM NaCl 
solution was incubated with mock (4 μL of 1x phosphate buffered saline that 
corresponds to equal volume of HSP70-inhibitor solution) or 100 μM VER155008 
(HSP70-inhibitor) or with 50 μg of isotype control or anti-HSP70 antibodies (Cell 
Signaling technologies, USA). The whole mix of salivary glands with 150 mM NaCl was 
then added to 15 μL of fibrinogen solutions making up a total volume of 20 μL. From 20 
μL reaction mix, 3 μL was immediately taken out and considered as 0 min time point 
sample. Incubation was then continued and 3 μL sample was collected at different time 
points (15, 30, 120 and 240 minutes). The collected samples were stored on ice until 
further use. All samples were heated at 70°C for 3 min before loading on to 4-20% 
gradient stain-free SDS-PAGE gels (BioRad). 12% SDS-PAGE gels were used for 
HSP70-inhibitor or antibody-blocking fibrinogenolysis assays. Images for fibrinogen 
degradation were captured using Chemidoc MP Imager (BioRad).  
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RNA Isolation and qRT-PCR  
Total RNA from fed larvae or salivary glands from nymphs was generated using 
the Aurum Total RNA mini kit (BioRad, USA) following the manufacturer’s instructions. 
RNA was converted to cDNA using cDNA synthesis kit (BioRad, Hercules, USA).  
Standard curve was prepared using 10-fold serial dilutions starting from 1 ng to 0.00001 
ng of known quantities of hsp70-like molecules or actin fragments and qRT-PCR 
reactions were performed as described (Kotsyfakis et al., 2006). The generated cDNA 
was used as a template for quantifying transcripts of tick hsp70-like molecules. As an 
internal control and to normalize the amount of template, I. scapularis actin transcripts 
were quantified using oligonucleotides 5’ GGTATCGTGCTCGACTC3’ and 5’ 
CAGGGCGACGTAGCAG 3’. QRT-PCR was performed using iQ-SYBR Green 
Supermix (Biorad, USA). Following are the oligonucleotide primers used in this study: 
XM_002433611, 5’-GAGTTTTCAAGAATGGGCGTGT-3’ and  
5’-GTGAGGCTTGCTGTTCTTGTCC-3’; XM_002407088,  
5’-CGGCTGATCGGTCGTCGT-3’ and 5’ CGCTGCGAGTCGTTGAAGT 3’; 
XM_002406516,  
5’-GCGGAACACGGAGAACACAGT-3’ and 5’-GAACCTCTTCCGCTCTCCCT-3’; 
XM_002412155, 5’-GATGACCCCAAGATTCAGCAG-3’ and  
5’-GCCTCGGCTGTTTCTTTCATCT-3’; XM_002415881, 
 5’-GAAAGAAACGGCGGAGGCT-3’ and 5’-CGTGGGCTCGTTGATGATG-3’; 
XM_002402518, 5’-GTGTAGCAGTGATGGAAGGGAAGA-3’ and  
5’-CAGAGAGGGTGTTGGACGCA-3’.  
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Tick Weight Measurements 
Fed ticks were collected immediately after repletion, cleaned with brushes to 
remove any mice hair or feces and weighed using a Cahn C-31 microbalance 
(Thermoelectric Co., West Chester, PA) set to a range from 25 mg to 0.1 μg. Total body 
weight measurements were obtained by directly placing each tick on a balance pan.  
Data in Figure 17 shows the total tick body weights for at least 75 larvae/group. 
 
Immunoblotting and Densitometry  
Total lysates from 5-7 ticks fed on C57BL/6J or RAG-/- mice and BALB/c or SCID 
NCr was prepared in modified RIPA buffer (BioExpress) supplemented with EDTA-free 
protease inhibitor cocktail (Sigma, USA). Protein concentrations were determined by 
BCA protein assay kit (Pierce, USA). Thirty micrograms of total lysates from each group 
were loaded onto a 12% non-reducing stain-free SDS-PAGE gel (BioRad) for D-dimer 
immunoblotting. In addition, D-dimer protein that was purified from human plasma was 
purchased from Lee Biosolutions (MO, USA) and was used in immunoblotting assays 
performed on 10% SDS-PAGE gels. The protein gels were further processed for 
immunoblotting as described (Sultana et al., 2010). D-dimer antibody (Biorbyt, UK) and 
Rabbit polyclonal anti-IgG HRP-conjugated antibody (Santa Cruz Biotechnology Inc.) 
was used to detect D-dimer. ECL reactions were performed using Advanced 
WesternBright ECL HRP substrate kit (Advansta, USA) and chemi-luminescence 
reaction images were captured using Chemidoc MP Imager (BioRad). Densitometry 
analysis was performed using image lab software 4 by measuring intensity of D-dimer 
bands relative to the control band (equal loading control) from the stain-free image. For 
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fibrinogenolysis assays, densitometry analysis was performed by measuring intensity of 
the degraded product band relative to the level of fibrinogen Aα at 0 min time point. 
Salivary Gland Dissection  
Salivary glands and gut tissues were dissected from individual freshly fed 
nymphal ticks in sterile 1X phosphate buffer saline. The tissues were then pooled in one 
vial and homogenized using Kontes homogenizer and disposable pestles (VWR, USA). 
Protein concentrations were determined by BCA protein assay kit (Pierce, USA). Five 
micrograms of salivary gland extracts were used for fibrinogenolysis assays. 
 
Mass Spectrometry Analysis  
The tick samples were run on a 1-D gel for dual purposes of sample 
concentration and sample clean-up. This gel is stained with Coomassie Blue was de-
stained and washed with a series of three washing buffers (50 mM ammonium 
bicarbonate, 50% acetonitrile and 80% acetonitrile). The bound proteins were reduced 
with 1 mL of 40 mM dithiothreitol for 25 minutes at 56°C. The gels were rinsed with 1 
mL of 50 mM ammonium bicarbonate buffer and the reduced proteins were alkylated 
with 1 mL of 50 mM Iodoacetamide for 30 minutes at 25°C in the dark with constant 
mixing. The Iodoacetamide was discarded and the gel bound proteins were digested 
with 0.5 mL of trypsin (20 ng/µL; Promega, Madison, WI) in 50 mM ammonium 
bicarbonate buffer at 37°C with constant mixing for 12 h. After digestion, the tryptic 
fraction was collected, and the gels were washed with 50mM ammonium bicarbonate to 
collect any remaining tryptic peptides. The eluent containing the tryptic peptides were 
dried using a Speed-Vac apparatus (Thermo Fisher Scientific, San Jose, CA) and 
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stored at 4°C prior to mass spectrometric analysis. The LC-MS/MS analysis was 
performed by Dr Sucharita Dutta for our published study (Vora et al., 2017). 
 
Peptide/Protein Acquisition by ESI-MS/MS Analysis  
The dried samples were dissolved with 20 µL of 0.1% formic acid/water. 2 µL of 
each sample was analyzed by LC/ESI-MS/MS using a Q-Exactive (Thermo Fisher) 
mass spectrometer with an Easy NanoLC-1000 system using data dependent 
acquisition with dynamic exclusion (DE = 1) settings. The data dependent acquisition 
settings used were a top 12 higher energy collision induced dissociation (HCD) for the 
Q-Exactive MS. The Q-Exactive mass spectrometer was used with capillary 
temperature, 250°C; spray voltage, 1600V; and S-lens voltage, 55%. The automatic 
gain control (AGC) target was3e6 for Full MS scans and 2e5 for MS/MS scans. 
Resolving power for Q-Exactive was set at 70,000 for the full MS scan, and 17,500 for 
the MS/MS scan at m/z 200. LC/ESI-MS/MS analyses was conducted using a C18 
column (75 µm x 150 mm). The mobile phases for the reverse phase chromatography 
were (A) 0.1% HCOOH/water and (B) 0.1% HCOOH in acetonitrile. A four-step, linear 
gradient was used for the LC separation (2% to 30% B in the first 47 minutes, followed 
by 80%B in the next 1 minute and holding at 80% B for 12 minutes). The LC-MS/MS 
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Peptide/Protein Identification from Tick Samples  
The Sequest algorithm was used to identify peptides from the resulting MS/MS 
spectra by searching against the combined tick protein database extracted from Uniprot 
using the appropriate taxonomy using Proteome Discoverer (version 1.3, 
ThermoScientific). Searching parameters for parent and fragment ion tolerances were 
set as 20 ppm and 30 mmu for the Q Exactive MS. Other parameters used were a fixed 
modification of carbamidomethylation –Cys, variable modifications of oxidation (Met). 
Trypsin was set as the protease with a maximum of 2 missed cleavages. Raw files and 
proteome discoverer search results for the target protein were input into the quantitative 
package; Pinpoint (version 1.1, ThermoScientific). The raw file was imported into the 
software which analyzed the data and determined the optimal peptide targets for the 
protein of interest. The software determines the retention time window and accurate m/z 
ratio for each targeted peptide and produced a mass list used directly in the acquisition 
method for scheduled MS/MS. Target m/z lists were generated automatically based on 
tryptic cleavage, specified modifications and retention time on the chromatogram 
obtained from the gel spots. Quantitation analysis was performed in an automated 
fashion using the software with a 5 ppm window for extracted ion chromatograms. The 
optimized acquisition method for the targeted peptides was run in triplicate to validate 
the quantitative differences observed in the samples from the discovery experiment. 
Label free differential analysis was performed to compare the four sets of tick samples 
after sample normalization. The LC-MS/MS analysis was performed by Dr. Sucharita 
Dutta for our published study (Vora et al., 2017). 
 




The statistical significance of differences observed in data sets was analyzed 
using GraphPad Prism6 software and Microsoft Excel. For data to compare two means, 
the non-paired Student t test was performed. p values of < 0.05 were considered 
significant in all tests. Wherever necessary, statistical test and p values are reported. 
 
  





 These two studies provide an insight into how vector molecules could influence 
pathogen transmission in different ways. This adds to the range of the vector and 
pathogen molecular repertoire that can be used upon the host to make infections easier 
to transmit and establish in arthropod and vertebrate hosts. In the first study involving 
the transmission of dengue virus through EVs and facilitated by Tsp29Fb, some very 
important new phenomenon were observed. This study is the first to show that mosquito 
cells can produce EVs. Recent studies from Dr. Sultana’s laboratory shows the 
production of EVs by tick cells and that these can mediate Langat virus and West Nile 
Virus infection in vitro (Zhou et al., 2018). This study is also the first to show the 
presence of an entire genome of DENV2 inside EVs. The study was also able to show 
the presence of RNA from another serotype, DENV3 inside EVs which together with 
(Zhou et al., 2018) indicates that other flaviviruses could be exhibiting similar strategies. 
In addition, the study showed the presence of dengue proteins in the EVs, indicating 
that once the RNA is introduced inside naïve cells, it has some viral proteins available to 
readily start replicating. Although this study is not the first in showing that EVs derived 
from virus infected cells can propagate infection, the data showing flaviviral content-
carrying EVs being infectious is of special importance. It indicates that receptor-
mediated endocytosis may not be the only way for flaviviral entry, since EVs have been 
shown to directly fuse with recipient cells (Barile and Vassalli, 2017; Colombo et al., 
2014; Schorey et al., 2015; Théry et al., 2002). The identification of a mosquito ortholog 
of the human exosome marker CD63 provides a useful target for the abrogation of 
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dengue transmission. Inhibition of Tsp29Fb leads to the reduction in dengue load and 
transmission (through EVs) which fits the first criteria of a good candidate for blocking 
the transmission of VBDs (Neelakanta and Sultana, 2015).  
 In the second study, a novel approach in studying VBDs was undertaken. The 
study was designed to see the effect of the host on the vectors rather than the other 
way around as many other studies have done (Brossard and Wikel, 2004; Formaglio et 
al., 2018; Hovius et al., 2008; Ribeiro et al., 2007; Wikel, 2013, 1996). While trying to 
determine if the immunocompetence of hosts has an effect on the vector, the study 
discovered that I. scapularis ticks have a higher engorgement weight when they feed on 
immunocompromised hosts. The salivary gland extracts from the same ticks when 
exposed to fibrinogen showed greater fibrinogenolysis in the immunocompetent host-
fed cohort. This indicates that a vector factor was not being induced during feeding and 
that it was probably involved in the disruption of the host’s coagulation machinery, which 
was not being triggered due to the absence of or weak effect of that pathway in 
immunocompromised hosts. Though the tested metalloproteases were not involved in 
this effect, the tick HSP70-like molecule was shown to be involved in the proteolysis of 
fibrinogen. Thus indicating its role in disruption of the host’s coagulation response. The 
significance of this study is that since the vectors take a larger blood meal or feed for 
longer, they may have a higher chance of transmitting any pathogens they may be 
carrying to hosts that are already immunocompromised. To firmly place this molecule as 
a good candidate for transmission blocking, further studies involving pathogens need to 
be performed.  
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 In summary, the development of vector-borne disease prevention and cure 
needs urgent attention due to its high mortality rate. Vector-borne diseases also offer 
exciting avenues for infectious disease research through the sheer number of 
interactions and players that are involved at the vector-host-pathogen interface. 
Strategies for establishing safe, effective and cheap transmission blocking vaccines 
remain under investigation. 
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